Todd A. Alonzo, PhD

Title(s)Professor of Research Population and Public Health Sciences
SchoolKeck School of Medicine of Usc
Address2001 N. Soto Street
Health Sciences Campus
Los Angeles CA 90033
Phone+1 626 241 1522
vCardDownload vCard
    Other Positions
    Title(s)Group Statistician for Children's Oncology Group


    Collapse Biography 
    Collapse Awards and Honors
    2018Fellow, American Statistical Association
    The International Society for Magnetic Resonance in Medicine2017Outstanding Teacher Award
    University of Washington2000Senior Biostatistics Award, Department of Biostatistics
    1999ENAR Biometrics Society Distinguished Student Paper Award
    1999WNAR Biometrics Society Best Student Oral Presentation
    NIH1995Predoctoral Cardiovascular Biostatistics Training Grant

    Collapse Overview 
    Collapse Overview
    Todd Alonzo is a Professor of Research in the Department of Preventive Medicine, University of Southern California. He received his undergraduate degree at the California State Polytechnic University, San Luis Obispo, California in Statistics in 1994 and received both his MS and his PhD in Biostatistics in 1997 and 2000 from the University of Washington, Seattle. Dr. Alonzo’s main areas of research interest are the statistical methods for analysis of biomarkers and medical diagnostic and screening tests, clinical trials, and the design and analysis of pediatric acute myelogenous leukemia studies. He has published over 225 peer-reviewed articles.

    Dr. Alonzo has been member of the Editorial Board for Biometrics, Pediatric Blood Cancer, and Biometrical Journal and has acted as a reviewer for 30 scientific journals. He is a member of several Data Safety and Monitoring Boards. Dr. Alonzo was the President of the International Biometric Society Western Northern America Region (WNAR) in 2009. He is a Fellow of the American Statistical Association.

    Collapse Research 
    Collapse Research Activities and Funding
    Children's Oncology Group Statistics and Data Center
    NIH U10CA180899Apr 15, 2014 - Feb 28, 2025
    Role: Co-Principal Investigator
    Bias correction optimizes the choice of screening test for early cancer detection
    NIH R03CA136048Sep 1, 2009 - Aug 31, 2012
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Phase II study of vemurafenib in children and young adults with tumors harboring BRAF V600 mutations: NCI-COG pediatric MATCH trial (APEC1621) Arm G. Oncologist. 2024 Aug 05; 29(8):723-e1093. Nelson MV, Kim A, Williams PM, Roy-Chowdhuri S, Patton DR, Coffey BD, Reid JM, Piao J, Saguilig L, Alonzo TA, Berg SL, Ramirez NC, Jaju A, Fox E, Weigel BJ, Hawkins DS, Mooney MM, Takebe N, Tricoli JV, Janeway KA, Seibel NL, Parsons DW. PMID: 38873934; PMCID: PMC11299954.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    2. Integrated drug resistance and leukemic stemness gene-expression scores predict outcomes in large cohort of over 3500 AML patients from 10 trials. NPJ Precis Oncol. 2024 Aug 01; 8(1):168. H Elsayed A, Cao X, Marrero RJ, Nguyen NHK, Wu H, Ni Y, Ribeiro RC, Tobias H, Valk PJ, Béliveau F, Richard-Carpentier G, Hébert J, Zwaan CM, Gamis A, Kolb EA, Aplenc R, Alonzo TA, Meshinchi S, Rubnitz J, Pounds S, Lamba JK. PMID: 39090192; PMCID: PMC11294346.
      View in: PubMed   Mentions:
    3. Sociodemographic Factors Correlate with Late Stage Pediatric Hodgkin Lymphoma and Rhabdomyosarcoma: A Report from the Children's Oncology Group Registries. Cancer Epidemiol Biomarkers Prev. 2024 Jul 31. Ou JY, Kaddas HK, Alonzo TA, Spector LG, Fallahazad N, Owens E, Collin LJ, Green AL, Kirchhoff AC. PMID: 39083086.
      View in: PubMed   Mentions:    Fields:    
    4. Gynecologic infection rates after ablation treatment for cervical intraepithelial neoplasia grade 2 and higher (CIN2+): Secondary analysis of a non-inferiority randomized trial. PLOS Glob Public Health. 2024; 4(7):e0003333. Masch R, Conzuelo-Rodriguez G, Mitchell JA, Alfaro K, Soler M, Chavez LF, Wu S, Sun J, Hu L, Marinela-Hernandez D, Alonzo TA, Felix JC, Cremer ML. PMID: 38985817; PMCID: PMC11236093.
      View in: PubMed   Mentions:
    5. Olaparib for childhood tumors harboring defects in DNA damage repair genes: arm H of the NCI-COG Pediatric MATCH trial. Oncologist. 2024 Jul 05; 29(7):638-e952. Glade Bender JL, Pinkney K, Williams PM, Roy-Chowdhuri S, Patton DR, Coffey BD, Reid JM, Piao J, Saguilig L, Alonzo TA, Berg SL, Ramirez NC, Fox E, Weigel BJ, Hawkins DS, Mooney MM, Takebe N, Tricoli JV, Janeway KA, Seibel NL, Parsons DW. PMID: 38815151; PMCID: PMC11224971.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsCTClinical Trials
    6. Optimized cytogenetic risk-group stratification of KMT2A-rearranged pediatric acute myeloid leukemia. Blood Adv. 2024 Jun 25; 8(12):3200-3213. van Weelderen RE, Harrison CJ, Klein K, Jiang Y, Abrahamsson J, Alonzo T, Aplenc R, Arad-Cohen N, Bart-Delabesse E, Buldini B, De Moerloose B, Dworzak MN, Elitzur S, Fernández Navarro JM, Gamis A, Gerbing RB, Goemans BF, de Groot-Kruseman HA, Guest E, Ha SY, Hasle H, Kelaidi C, Lapillonne H, Leverger G, Locatelli F, Miyamura T, Norén-Nyström U, Polychronopoulou S, Rasche M, Rubnitz JE, Stary J, Tierens A, Tomizawa D, Zwaan CM, Kaspers GJL. PMID: 38621200; PMCID: PMC11225675.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. EZH2-driven immune evasion defines high-risk pediatric AML with t(16;21) FUS::ERG gene fusion. bioRxiv. 2024 Jun 25. Buteyn NJ, Burke CG, Sartori VJ, Deering-Gardner E, DeBruine ZJ, Kamarudin D, Chandler DP, Monovich AC, Perez MW, Yi JS, Ries RE, Alonzo TA, Ryan RJ, Meshinchi S, Triche TJ. PMID: 38798454; PMCID: PMC11118270.
      View in: PubMed   Mentions:
    8. Cardiotoxicity of CPX-351 in children and adolescents with relapsed AML: a Children's Oncology Group report. Front Cardiovasc Med. 2024; 11:1347547. Leger KJ, Absalon MJ, Demissei BG, Smith AM, Gerbing RB, Alonzo TA, Narayan HK, Hirsch BA, Pollard JA, Razzouk BI, Getz KD, Aplenc R, Kolb EA, Ky B, Cooper TM. PMID: 38947228; PMCID: PMC11211570.
      View in: PubMed   Mentions:
    9. Phase II Study of Ulixertinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Alterations: APEC1621J of the National Cancer Institute-Children's Oncology Group Pediatric MATCH Trial. JCO Precis Oncol. 2024 Jun; 8:e2400103. Vo KT, Sabnis AJ, Williams PM, Roy-Chowdhuri S, Patton DR, Coffey B, Reid JM, Piao J, Saguilig L, Alonzo TA, Berg SL, Jaju A, Fox E, Weigel BJ, Hawkins DS, Mooney MM, Takebe N, Tricoli JV, Janeway KA, Seibel NL, Parsons DW. PMID: 38935895.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsCTClinical Trials
    10. Prognostic impact of cooccurring mutations in FLT3-ITD pediatric acute myeloid leukemia. Blood Adv. 2024 05 14; 8(9):2094-2103. Tarlock K, Gerbing RB, Ries RE, Smith JL, Leonti A, Huang BJ, Kirkey D, Robinson L, Peplinski JH, Lange B, Cooper TM, Gamis AS, Kolb EA, Aplenc R, Pollard JA, Alonzo TA, Meshinchi S. PMID: 38295280; PMCID: PMC11063409.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    11. Structural variants involving MLLT10 fusion are associated with adverse outcomes in pediatric acute myeloid leukemia. Blood Adv. 2024 Apr 23; 8(8):2005-2017. Abla O, Ries RE, Triche T, Gerbing RB, Hirsch B, Raimondi S, Cooper T, Farrar JE, Buteyn N, Harmon LM, Wen H, Deshpande AJ, Kolb EA, Gamis AS, Aplenc R, Alonzo T, Meshinchi S. PMID: 38306602; PMCID: PMC11024924.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    12. Characteristics and treatment of acute myeloid neoplasms with cutaneous involvement in infants up to 6 months of age: A retrospective study. Pediatr Blood Cancer. 2024 Jul; 71(7):e31006. Renaud J, Goemans BF, Locatelli F, Pigazzi M, Redmond S, Kuehni CE, Destaillats A, Alonzo TA, Gerbing RB, Gamis A, Aplenc R, Renella R, Cooper T, Ceppi F. PMID: 38616361.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. Chromatin Profiles Are Prognostic of Clinical Response to Bortezomib-Containing Chemotherapy in Pediatric Acute Myeloid Leukemia: Results from the COG AAML1031 Trial. Cancers (Basel). 2024 Apr 09; 16(8). van Dijk AD, Hoff FW, Qiu Y, Hubner SE, Go RL, Ruvolo VR, Leonti AR, Gerbing RB, Gamis AS, Aplenc R, Kolb EA, Alonzo TA, Meshinchi S, de Bont ESJM, Horton TM, Kornblau SM. PMID: 38672531; PMCID: PMC11048007.
      View in: PubMed   Mentions:
    14. CD74 is expressed in a subset of pediatric acute myeloid leukemia patients and is a promising target for therapy: a report from the Children's Oncology Group. Haematologica. 2024 Feb 01. Menssen AJ, Hudson CA, Alonzo T, Gerbing R, Pardo L, Leonti A, Cook JA, Hsu FC, Lott LL, Dai F, Fearing C, Ghirardelli K, Hylkema T, Tarlock K, Loeb KR, Kolb EA, Cooper T, Pollard J, Wells DA, Loken MR, Aplenc R, Meshinchi S, Brodersen LE. PMID: 38299667.
      View in: PubMed   Mentions:    Fields:    
    15. Bayesian semiparametric model for sequential treatment decisions with informative timing. Biostatistics. 2024 Jan 16. Oganisian A, Getz KD, Alonzo TA, Aplenc R, Roy JA. PMID: 38230584.
      View in: PubMed   Mentions:    Fields:    
    16. A new genomic framework to categorize pediatric acute myeloid leukemia. Nat Genet. 2024 Feb; 56(2):281-293. Umeda M, Ma J, Westover T, Ni Y, Song G, Maciaszek JL, Rusch M, Rahbarinia D, Foy S, Huang BJ, Walsh MP, Kumar P, Liu Y, Yang W, Fan Y, Wu G, Baker SD, Ma X, Wang L, Alonzo TA, Rubnitz JE, Pounds S, Klco JM. PMID: 38212634; PMCID: PMC10864188.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    17. Genetic variation in DNA damage response pathway and response to Gemtuzumab Ozogamicin in pediatric AML: a report from the Children's Oncology Group. Clin Cancer Res. 2024 Jan 10. Shastri VM, Chauhan L, Gbadamosi M, Alonzo TA, Wang YC, Aplenc R, Hirsch BA, Kolb EA, Gamis AS, Meshinchi S, Lamba JK. PMID: 38197878; PMCID: PMC11233425.
      View in: PubMed   Mentions:    Fields:    
    18. Population-Based Data Linkage Describing Patterns of Cancer Clinical Trial Enrollment Among Children and Adolescents. JCO Oncol Pract. 2024 May; 20(5):631-642. Siegel DA, Durbin EB, Pollock BH, Grimes A, Ji L, Alonzo TA, Vargas SL, Huang B, McDowell JR, Lycan E, Ransdell P, Tai E, Roth ME, Freyer DR. PMID: 38194612; PMCID: PMC11090697.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    19. Rationale and design of the Children's Oncology Group study AAML1831 integrated cardiac substudies in pediatric acute myeloid leukemia therapy. Front Cardiovasc Med. 2023; 10:1286241. Leger KJ, Robison N, Narayan HK, Smith AM, Tsega T, Chung J, Daniels A, Chen Z, Englefield V, Demissei BG, Lefebvre B, Morrow G, Dizon I, Gerbing RB, Pabari R, Getz KD, Aplenc R, Pollard JA, Chow EJ, Tang WHW, Border WL, Sachdeva R, Alonzo TA, Kolb EA, Cooper TM, Ky B. PMID: 38107263; PMCID: PMC10722184.
      View in: PubMed   Mentions:
    20. Association of the social disorganization index with time to first septic shock event in children with acute myeloid leukemia. Cancer. 2024 03 15; 130(6):962-972. Ruiz J, Li Y, Cao L, Huang YV, Tam V, Griffis HM, Winestone LE, Fisher BT, Alonzo TA, Wang YJ, Dang AT, Kolb EA, Glanz K, Getz KD, Aplenc R, Seif AE. PMID: 37985388; PMCID: PMC10922804.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    21. Tazemetostat for tumors harboring SMARCB1/SMARCA4 or EZH2 alterations: results from NCI-COG pediatric MATCH APEC1621C. J Natl Cancer Inst. 2023 11 08; 115(11):1355-1363. Chi SN, Yi JS, Williams PM, Roy-Chowdhuri S, Patton DR, Coffey BD, Reid JM, Piao J, Saguilig L, Alonzo TA, Berg SL, Ramirez NC, Jaju A, Mhlanga JC, Fox E, Hawkins DS, Mooney MM, Takebe N, Tricoli JV, Janeway KA, Seibel NL, Parsons DW. PMID: 37228094; PMCID: PMC11009504.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    22. Characteristics and prognostic impact of IDH mutations in AML: a COG, SWOG, and ECOG analysis. Blood Adv. 2023 10 10; 7(19):5941-5953. Zarnegar-Lumley S, Alonzo TA, Gerbing RB, Othus M, Sun Z, Ries RE, Wang J, Leonti A, Kutny MA, Ostronoff F, Radich JP, Appelbaum FR, Pogosova-Agadjanyan EL, O'Dwyer K, Tallman MS, Litzow M, Atallah E, Cooper TM, Aplenc RA, Abdel-Wahab O, Gamis AS, Luger S, Erba H, Levine R, Kolb EA, Stirewalt DL, Meshinchi S, Tarlock K. PMID: 37267439; PMCID: PMC10562769.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    23. Comprehensive molecular and clinical characterization of NUP98 fusions in pediatric acute myeloid leukemia. Haematologica. 2023 08 01; 108(8):2044-2058. Bertrums EJM, Smith JL, Harmon L, Ries RE, Wang YJ, Alonzo TA, Menssen AJ, Chisholm KM, Leonti AR, Tarlock K, Ostronoff F, Pogosova-Agadjanyan EL, Kaspers GJL, Hasle H, Dworzak M, Walter C, Muhlegger N, Morerio C, Pardo L, Hirsch B, Raimondi S, Cooper TM, Aplenc R, Gamis AS, Kolb EA, Farrar JE, Stirewalt D, Ma X, Shaw TI, Furlan SN, Brodersen LE, Loken MR, Van den Heuvel-Eibrink MM, Zwaan CM, Triche TJ, Goemans BF, Meshinchi S. PMID: 36815378; PMCID: PMC10388277.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    24. Information fraction estimation: Strategies for a phase 3 non-inferiority maximum duration design with time to event outcome. Pharm Stat. 2023 Nov-Dec; 22(6):1031-1045. Dang HM, Krailo MD, Alonzo TA, Mack WJ, Kairalla JA. PMID: 37496113; PMCID: PMC10811287.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    25. Children's Oncology Group's 2023 blueprint for research: Myeloid neoplasms. Pediatr Blood Cancer. 2023 09; 70 Suppl 6:e30584. Cooper TM, Alonzo TA, Tasian SK, Kutny MA, Hitzler J, Pollard JA, Aplenc R, Meshinchi S, Kolb EA. PMID: 37480164; PMCID: PMC10614720.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    26. Reply to Z.R. McCaw et al. J Clin Oncol. 2023 09 20; 41(27):4447. Farrar JE, Othus M, Wang YC, Alonzo TA, Meshinchi S. PMID: 37390387; PMCID: PMC10522099.
      View in: PubMed   Mentions:    Fields:    
    27. SAMHD1 single nucleotide polymorphisms impact outcome in children with newly diagnosed acute myeloid leukemia. Blood Adv. 2023 06 13; 7(11):2538-2550. Marrero RJ, Cao X, Wu H, Elsayed AH, Klco JM, Ribeiro RC, Rubnitz JE, Ma X, Meshinchi S, Aplenc R, Kolb EA, Ries RE, Alonzo TA, Pounds SB, Lamba JK. PMID: 36689724; PMCID: PMC10242642.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    28. Valosin-containing protein (VCP/p97) is prognostically unfavorable in pediatric AML, and negatively correlates with unfolded protein response proteins IRE1 and GRP78: A report from the Children's Oncology Group. Proteomics Clin Appl. 2023 Nov; 17(6):e2200109. Hoff FW, Qiu Y, Brown BD, Gerbing RB, Leonti AR, Ries RE, Gamis AS, Aplenc R, Kolb EA, Alonzo TA, Meshinchi S, Jenkins GN, Horton TM, Kornblau SM. PMID: 37287368; PMCID: PMC10700663.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    29. CREBBP alterations are associated with a poor prognosis in de novo AML. Blood. 2023 04 27; 141(17):2156-2159. Lamble AJ, Hagiwara K, Gerbing RB, Smith JL, Kolekar P, Ries RE, Kolb EA, Alonzo TA, Ma X, Meshinchi S. PMID: 36634304; PMCID: PMC10273087.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    30. Etiology of oncogenic fusions in 5,190 childhood cancers and its clinical and therapeutic implication. Nat Commun. 2023 04 05; 14(1):1739. Liu Y, Klein J, Bajpai R, Dong L, Tran Q, Kolekar P, Smith JL, Ries RE, Huang BJ, Wang YC, Alonzo TA, Tian L, Mulder HL, Shaw TI, Ma J, Walsh MP, Song G, Westover T, Autry RJ, Gout AM, Wheeler DA, Wan S, Wu G, Yang JJ, Evans WE, Loh M, Easton J, Zhang J, Klco JM, Meshinchi S, Brown PA, Pruett-Miller SM, Ma X. PMID: 37019972; PMCID: PMC10076316.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    31. Long Noncoding RNA Expression Independently Predicts Outcome in Pediatric Acute Myeloid Leukemia. J Clin Oncol. 2023 06 01; 41(16):2949-2962. Farrar JE, Smith JL, Othus M, Huang BJ, Wang YC, Ries R, Hylkema T, Pogosova-Agadjanyan EL, Challa S, Leonti A, Shaw TI, Triche TJ, Gamis AS, Aplenc R, Kolb EA, Ma X, Stirewalt DL, Alonzo TA, Meshinchi S. PMID: 36795987; PMCID: PMC10414715.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    32. Pathologic, cytogenetic, and molecular features of acute myeloid leukemia with megakaryocytic differentiation: A report from the Children's Oncology Group. Pediatr Blood Cancer. 2023 05; 70(5):e30251. Chisholm KM, Smith J, Heerema-McKenney AE, Choi JK, Ries RE, Hirsch BA, Raimondi SC, Wang YC, Dang A, Alonzo TA, Sung L, Aplenc R, Gamis AS, Meshinchi S, Kahwash SB. PMID: 36789545; PMCID: PMC10038909.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    33. Comparison of design methods for a safety run-in phase of a phase II clinical trial. Clin Trials. 2023 04; 20(2):181-191. Ji L, Alonzo TA. PMID: 36628921; PMCID: PMC10324475.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    34. Safety and Acceptability of Three Ablation Treatments for High-Grade Cervical Precancer: Early Data From a Randomized Noninferiority Clinical Trial. JCO Glob Oncol. 2022 12; 8:e2200112. Soler M, Alfaro K, Masch RJ, Conzuelo Rodriguez G, Qu X, Wu S, Sun J, Hernández Jovel DM, Bonilla J, Puentes LO, Murillo R, Alonzo TA, Felix JC, Castle P, Cremer M. PMID: 36525620; PMCID: PMC10166394.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    35. Clinical relevance of proteomic profiling in de novo pediatric acute myeloid leukemia: a Children's Oncology Group study. Haematologica. 2022 10 01; 107(10):2329-2343. Hoff FW, Van Dijk AD, Qiu Y, Hu CW, Ries RE, Ligeralde A, Jenkins GN, Gerbing RB, Gamis AS, Aplenc R, Kolb EA, Alonzo TA, Meshinchi S, Qutub AA, De Bont ESJM, Horton TM, Kornblau SM. PMID: 35021602; PMCID: PMC9521248.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    36. Integrated stem cell signature and cytomolecular risk determination in pediatric acute myeloid leukemia. Nat Commun. 2022 09 19; 13(1):5487. Huang BJ, Smith JL, Farrar JE, Wang YC, Umeda M, Ries RE, Leonti AR, Crowgey E, Furlan SN, Tarlock K, Armendariz M, Liu Y, Shaw TI, Wei L, Gerbing RB, Cooper TM, Gamis AS, Aplenc R, Kolb EA, Rubnitz J, Ma J, Klco JM, Ma X, Alonzo TA, Triche T, Meshinchi S. PMID: 36123353; PMCID: PMC9485122.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    37. Automated Ascertainment of Typhlitis From the Electronic Health Record. JCO Clin Cancer Inform. 2022 09; 6:e2200081. Miller TP, Li Y, Masino AJ, Vallee E, Burrows E, Ramos M, Alonzo TA, Gerbing R, Castellino SM, Hawkins DS, Lash TL, Aplenc R, Grundmeier RW. PMID: 36198128; PMCID: PMC9848554.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    38. Rates of laboratory adverse events by course in paediatric leukaemia ascertained with automated electronic health record extraction: a retrospective cohort study from the Children's Oncology Group. Lancet Haematol. 2022 Sep; 9(9):e678-e688. Miller TP, Getz KD, Li Y, Demissei BG, Adamson PC, Alonzo TA, Burrows E, Cao L, Castellino SM, Daves MH, Fisher BT, Gerbing R, Grundmeier RW, Krause EM, Lee J, Lupo PJ, Rabin KR, Ramos M, Scheurer ME, Wilkes JJ, Winestone LE, Hawkins DS, Gramatges MM, Aplenc R. PMID: 35870472; PMCID: PMC9444944.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    39. Inefficiency of two-stage designs in phase II oncology clinical trials with high proportion of inevaluable patients. Contemp Clin Trials. 2022 09; 120:106849. Ji L, Whangbo J, Levine JE, Alonzo TA. PMID: 35868503; PMCID: PMC9489679.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    40. IL-10 and TNFα are associated with decreased survival in low-risk pediatric acute myeloid leukemia; a children's oncology group report. Pediatr Hematol Oncol. 2023 Mar; 40(2):147-158. Stevens AM, Horton TM, Glasser CL, Gerbing RB, Aplenc R, Alonzo TA, Redell MS. PMID: 35838057; PMCID: PMC10498011.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    41. A ten-gene DNA-damage response pathway gene expression signature predicts gemtuzumab ozogamicin response in pediatric AML patients treated on COGAAML0531 and AAML03P1 trials. Leukemia. 2022 08; 36(8):2022-2031. Gbadamosi MO, Shastri VM, Elsayed AH, Ries R, Olabige O, Nguyen NHK, De Jesus A, Wang YC, Dang A, Hirsch BA, Alonzo TA, Gamis A, Meshinchi S, Lamba JK. PMID: 35688939; PMCID: PMC9357169.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    42. Integrated Genomic Analysis Identifies UBTF Tandem Duplications as a Recurrent Lesion in Pediatric Acute Myeloid Leukemia. Blood Cancer Discov. 2022 05 05; 3(3):194-207. Umeda M, Ma J, Huang BJ, Hagiwara K, Westover T, Abdelhamed S, Barajas JM, Thomas ME, Walsh MP, Song G, Tian L, Liu Y, Chen X, Kolekar P, Tran Q, Foy SG, Maciaszek JL, Kleist AB, Leonti AR, Ju B, Easton J, Wu H, Valentine V, Valentine MB, Liu YC, Ries RE, Smith JL, Parganas E, Iacobucci I, Hiltenbrand R, Miller J, Myers JR, Rampersaud E, Rahbarinia D, Rusch M, Wu G, Inaba H, Wang YC, Alonzo TA, Downing JR, Mullighan CG, Pounds S, Babu MM, Zhang J, Rubnitz JE, Meshinchi S, Ma X, Klco JM. PMID: 35176137; PMCID: PMC9780084.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    43. Phase II Study of Selumetinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Genetic Alterations: Arm E of the NCI-COG Pediatric MATCH Trial. J Clin Oncol. 2022 07 10; 40(20):2235-2245. Eckstein OS, Allen CE, Williams PM, Roy-Chowdhuri S, Patton DR, Coffey B, Reid JM, Piao J, Saguilig L, Alonzo TA, Berg SL, Ramirez NC, Jaju A, Mhlanga J, Fox E, Hawkins DS, Mooney MM, Takebe N, Tricoli JV, Janeway KA, Seibel NL, Parsons DW. PMID: 35363510; PMCID: PMC9273373.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    44. Actionable Tumor Alterations and Treatment Protocol Enrollment of Pediatric and Young Adult Patients With Refractory Cancers in the National Cancer Institute-Children's Oncology Group Pediatric MATCH Trial. J Clin Oncol. 2022 07 10; 40(20):2224-2234. Parsons DW, Janeway KA, Patton DR, Winter CL, Coffey B, Williams PM, Roy-Chowdhuri S, Tsongalis GJ, Routbort M, Ramirez NC, Saguilig L, Piao J, Alonzo TA, Berg SL, Fox E, Hawkins DS, Abrams JS, Mooney M, Takebe N, Tricoli JV, Seibel NL, NCI-COG Pediatric MATCH Team. PMID: 35353553; PMCID: PMC9273376.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansCTClinical Trials
    45. Sorafenib in Combination With Standard Chemotherapy for Children With High Allelic Ratio FLT3/ITD+ Acute Myeloid Leukemia: A Report From the Children's Oncology Group Protocol AAML1031. J Clin Oncol. 2022 06 20; 40(18):2023-2035. Pollard JA, Alonzo TA, Gerbing R, Brown P, Fox E, Choi J, Fisher B, Hirsch B, Kahwash S, Getz K, Levine J, Brodersen LE, Loken MR, Raimondi S, Tarlock K, Wood A, Sung L, Kolb EA, Gamis A, Meshinchi S, Aplenc R. PMID: 35349331; PMCID: PMC9197362.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    46. Obesity in children with acute promyelocytic leukemia: What is its prevalence and prognostic significance? Pediatr Blood Cancer. 2022 06; 69(6):e29613. Laurie KL, Lee P, Rademaker A, Alonzo TA, Wang YC, Powell BL, Wu D, Larson R, Kutny M, Gregory J, Hijiya N, Feusner J. PMID: 35322524; PMCID: PMC9553282.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    47. Blood Count Recovery Following Induction Therapy for Acute Myeloid Leukemia in Children Does Not Predict Survival. Cancers (Basel). 2022 Jan 26; 14(3). Pommert L, Cooper TM, Gerbing RB, Brodersen L, Loken M, Gamis A, Aplenc R, Alonzo TA, Kolb EA. PMID: 35158884; PMCID: PMC8833679.
      View in: PubMed   Mentions: 2  
    48. Polygenic Ara-C Response Score Identifies Pediatric Patients With Acute Myeloid Leukemia in Need of Chemotherapy Augmentation. J Clin Oncol. 2022 03 01; 40(7):772-783. Elsayed AH, Cao X, Mitra AK, Wu H, Raimondi S, Cogle C, Al-Mansour Z, Ribeiro RC, Gamis A, Kolb EA, Aplenc R, Alonzo TA, Meshinchi S, Rubnitz J, Pounds S, Lamba JK. PMID: 34990262; PMCID: PMC8887949.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    49. Assessment of Arsenic Trioxide and All-trans Retinoic Acid for the Treatment of Pediatric Acute Promyelocytic Leukemia: A Report From the Children's Oncology Group AAML1331 Trial. JAMA Oncol. 2022 Jan 01; 8(1):79-87. Kutny MA, Alonzo TA, Abla O, Rajpurkar M, Gerbing RB, Wang YC, Hirsch BA, Raimondi S, Kahwash S, Hardy KK, Hardy S, Meshinchi S, Gamis AS, Kolb EA, Feusner JH, Gregory J. PMID: 34762093; PMCID: PMC8587220.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCTClinical Trials
    50. Comparison of the Transcriptomic Signatures in Pediatric and Adult CML. Cancers (Basel). 2021 Dec 14; 13(24). Youn M, Smith SM, Lee AG, Chae HD, Spiteri E, Erdmann J, Galperin I, Jones LM, Donato M, Abidi P, Bittencourt H, Lacayo N, Dahl G, Aftandilian C, Davis KL, Matthews JA, Kornblau SM, Huang M, Sumarsono N, Redell MS, Fu CH, Chen IM, Alonzo TA, Eklund E, Gotlib J, Khatri P, Sweet-Cordero EA, Hijiya N, Sakamoto KM. PMID: 34944883; PMCID: PMC8699058.
      View in: PubMed   Mentions: 4  
    51. CBFB-MYH11 fusion transcripts distinguish acute myeloid leukemias with distinct molecular landscapes and outcomes. Blood Adv. 2021 12 14; 5(23):4963-4968. Huang BJ, Smith JL, Wang YC, Taghizadeh K, Leonti AR, Ries RE, Liu Y, Kolekar P, Tarlock K, Gerbing R, Crowgey E, Furlan SN, Shaw TI, Hagiwara K, Wei L, Cooper TM, Gamis AS, Aplenc R, Kolb EA, Farrar JE, Triche T, Alonzo TA, Ma X, Meshinchi S. PMID: 34547772; PMCID: PMC9153007.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    52. High-dose AraC is essential for the treatment of ML-DS independent of postinduction MRD: results of the COG AAML1531 trial. Blood. 2021 12 09; 138(23):2337-2346. Hitzler J, Alonzo T, Gerbing R, Beckman A, Hirsch B, Raimondi S, Chisholm K, Viola S, Brodersen L, Loken M, Tong S, Druley T, O'Brien M, Hijiya N, Heerema-McKenney A, Wang YC, Schore R, Taub J, Gamis A, Kolb EA, Berman JN. PMID: 34320162; PMCID: PMC8662073.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    53. CD123 Expression Is Associated With High-Risk Disease Characteristics in Childhood Acute Myeloid Leukemia: A Report From the Children's Oncology Group. J Clin Oncol. 2022 01 20; 40(3):252-261. Lamble AJ, Eidenschink Brodersen L, Alonzo TA, Wang J, Pardo L, Sung L, Cooper TM, Kolb EA, Aplenc R, Tasian SK, Loken MR, Meshinchi S. PMID: 34855461; PMCID: PMC8769096.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    54. Bortezomib is significantly beneficial for de novo pediatric AML patients with low phosphorylation of the NF-κB subunit RelA. Proteomics Clin Appl. 2022 03; 16(2):e2100072. van Dijk AD, Hoff FW, Qiu Y, Gerbing RB, Gamis AS, Aplenc R, Kolb EA, Alonzo TA, Meshinchi S, Jenkins GN, de Bont ESJM, Kornblau SM, Horton TM. PMID: 34719869; PMCID: PMC9041833.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    55. Outcomes of intensification of induction chemotherapy for children with high-risk acute myeloid leukemia: A report from the Children's Oncology Group. Pediatr Blood Cancer. 2021 12; 68(12):e29281. Elgarten CW, Wood AC, Li Y, Alonzo TA, Brodersen LE, Gerbing RB, Getz KD, Huang YV, Loken M, Meshinchi S, Pollard JA, Sung L, Woods WG, Kolb EA, Gamis AS, Aplenc R. PMID: 34596937; PMCID: PMC8717610.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    56. CEBPA-bZip mutations are associated with favorable prognosis in de novo AML: a report from the Children's Oncology Group. Blood. 2021 09 30; 138(13):1137-1147. Tarlock K, Lamble AJ, Wang YC, Gerbing RB, Ries RE, Loken MR, Brodersen LE, Pardo L, Leonti A, Smith JL, Hylkema TA, Woods WG, Cooper TM, Kolb EA, Gamis AS, Aplenc R, Alonzo TA, Meshinchi S. PMID: 33951732; PMCID: PMC8570058.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCellsCTClinical Trials
    57. Cytarabine dose reduction in patients with low-risk acute myeloid leukemia: A report from the Children's Oncology Group. Pediatr Blood Cancer. 2022 01; 69(1):e29313. Getz KD, Alonzo TA, Sung L, Meshinchi S, Gerbing RB, Raimondi S, Hirsch B, Loken M, Brodersen LE, Kahwash S, Choi J, Kolb EA, Gamis A, Aplenc R. PMID: 34472213; PMCID: PMC8919970.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    58. Cancer Informatics for Cancer Centers: Scientific Drivers for Informatics, Data Science, and Care in Pediatric, Adolescent, and Young Adult Cancer. JCO Clin Cancer Inform. 2021 08; 5:881-896. Kerlavage AR, Kirchhoff AC, Guidry Auvil JM, Sharpless NE, Davis KL, Reilly K, Reaman G, Penberthy L, Deapen D, Hwang A, Durbin EB, Gallotto SL, Aplenc R, Volchenboum SL, Heath AP, Aronow BJ, Zhang J, Vaske O, Alonzo TA, Nathan PC, Poynter JN, Armstrong G, Hahn EE, Wernli KJ, Greene C, DiGiovanna J, Resnick AC, Shalley ER, Nadaf S, Kibbe WA. PMID: 34428097; PMCID: PMC8763339.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCellsPHPublic Health
    59. Gemtuzumab Ozogamicin Improves Event-Free Survival and Reduces Relapse in Pediatric KMT2A-Rearranged AML: Results From the Phase III Children's Oncology Group Trial AAML0531. J Clin Oncol. 2021 10 01; 39(28):3149-3160. Pollard JA, Guest E, Alonzo TA, Gerbing RB, Loken MR, Brodersen LE, Kolb EA, Aplenc R, Meshinchi S, Raimondi SC, Hirsch B, Gamis AS. PMID: 34048275; PMCID: PMC8478392.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCTClinical Trials
    60. Survival Following Relapse in Children with Acute Myeloid Leukemia: A Report from AML-BFM and COG. Cancers (Basel). 2021 May 12; 13(10). Rasche M, Zimmermann M, Steidel E, Alonzo T, Aplenc R, Bourquin JP, Boztug H, Cooper T, Gamis AS, Gerbing RB, Janotova I, Klusmann JH, Lehrnbecher T, Mühlegger N, Neuhoff NV, Niktoreh N, Sramkova L, Stary J, Waack K, Walter C, Creutzig U, Dworzak M, Kaspers G, Kolb EA, Reinhardt D. PMID: 34066095; PMCID: PMC8151466.
      View in: PubMed   Mentions: 26  
    61. Mesothelin is a novel cell surface disease marker and potential therapeutic target in acute myeloid leukemia. Blood Adv. 2021 05 11; 5(9):2350-2361. Kaeding AJ, Barwe SP, Gopalakrishnapillai A, Ries RE, Alonzo TA, Gerbing RB, Correnti C, Loken MR, Broderson LE, Pardo L, Le QH, Tang T, Leonti AR, Smith JL, Chou CK, Xu M, Triche T, Kornblau SM, Kolb EA, Tarlock K, Meshinchi S. PMID: 33938941; PMCID: PMC8114558.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    62. Aberrantly low STAT3 and STAT5 responses are associated with poor outcome and an inflammatory gene expression signature in pediatric acute myeloid leukemia. Clin Transl Oncol. 2021 Oct; 23(10):2141-2154. Narayanan P, Man TK, Gerbing RB, Ries R, Stevens AM, Wang YC, Long X, Gamis AS, Cooper T, Meshinchi S, Alonzo TA, Redell MS. PMID: 33948920; PMCID: PMC8390401.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    63. Results of a phase 2, multicenter, single-arm, open-label study of lenalidomide in pediatric patients with relapsed or refractory acute myeloid leukemia. Pediatr Blood Cancer. 2021 07; 68(7):e28946. O'Brien MM, Alonzo TA, Cooper TM, Levine JE, Brown PA, Slone T, August KJ, Benettaib B, Biserna N, Poon J, Patturajan M, Chen N, Simcock M, Zimmerman L, Kolb EA. PMID: 33694257.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    64. Heat shock factor 1 (HSF1-pSer326) predicts response to bortezomib-containing chemotherapy in pediatric AML: a COG report. Blood. 2021 02 25; 137(8):1050-1060. Hoff FW, van Dijk AD, Qiu Y, Ruvolo PP, Gerbing RB, Leonti AR, Jenkins GN, Gamis AS, Aplenc R, Kolb EA, Alonzo TA, Meshinchi S, de Bont ESJM, Bruggeman SWM, Kornblau SM, Horton TM. PMID: 32959058; PMCID: PMC7907722.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCellsCTClinical Trials
    65. The clinical and biological characteristics of NUP98-KDM5A in pediatric acute myeloid leukemia. Haematologica. 2021 02 01; 106(2):630-634. Noort S, Wander P, Alonzo TA, Smith J, Ries RE, Gerbing RB, Dolman MEM, Locatelli F, Reinhardt D, Baruchel A, Stary J, Molenaar JJ, Stam RW, van den Heuvel-Eibrink MM, Zwaan MC, Meshinchi S. PMID: 32381579; PMCID: PMC7849578.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    66. Acute erythroid leukemia is enriched in NUP98 fusions: a report from the Children's Oncology Group. Blood Adv. 2020 12 08; 4(23):6000-6008. Chisholm KM, Heerema-McKenney AE, Choi JK, Smith J, Ries RE, Hirsch BA, Raimondi SC, Alonzo TA, Wang YC, Aplenc R, Sung L, Gamis AS, Meshinchi S, Kahwash SB. PMID: 33284945; PMCID: PMC7724911.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    67. Morphologic remission status is limited compared to ΔN flow cytometry: a Children's Oncology Group AAML0531 report. Blood Adv. 2020 10 27; 4(20):5050-5061. Brodersen LE, Gerbing RB, Pardo ML, Alonzo TA, Paine D, Fritschle W, Hsu FC, Pollard JA, Aplenc R, Kahwash SB, Hirsch B, Ramondi S, Wells D, Kolb EA, Gamis AS, Meshinchi S, Loken MR. PMID: 33080007; PMCID: PMC7594384.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    68. Outcomes for Step-Wise Implementation of a Human Papillomavirus Testing-Based Cervical Screen-and-Treat Program in El Salvador. JCO Glob Oncol. 2020 10; 6:1519-1530. Alfaro K, Maza M, Felix JC, Gage JC, Castle PE, Alonzo TA, Chacón A, González E, Soler M, Conzuelo-Rodriguez G, Masch R, Cremer M. PMID: 33064628; PMCID: PMC7605377.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCellsCTClinical Trials
    69. Information fraction estimation based on the number of events within the standard treatment regimen. Biom J. 2020 Dec; 62(8):1960-1972. Dang HM, Alonzo T, Franklin M, Mack WJ, Krailo MD, Eckel SP. PMID: 32627859; PMCID: PMC7953992.
      View in: PubMed   Mentions: 1     Fields:    
    70. Phase I/II Study of CPX-351 Followed by Fludarabine, Cytarabine, and Granulocyte-Colony Stimulating Factor for Children With Relapsed Acute Myeloid Leukemia: A Report From the Children's Oncology Group. J Clin Oncol. 2020 07 01; 38(19):2170-2177. Cooper TM, Absalon MJ, Alonzo TA, Gerbing RB, Leger KJ, Hirsch BA, Pollard J, Razzouk BI, Aplenc R, Kolb EA. PMID: 32401633; PMCID: PMC7325367.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCTClinical Trials
    71. Prognostic impact of CSF3R mutations in favorable risk childhood acute myeloid leukemia. Blood. 2020 04 30; 135(18):1603-1606. Tarlock K, Alonzo T, Wang YC, Gerbing RB, Ries RE, Hylkema T, Smith JL, Maxson JE, Meshinchi S. PMID: 32187354; PMCID: PMC7193184.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    72. Effect of Dexrazoxane on Left Ventricular Systolic Function and Treatment Outcomes in Patients With Acute Myeloid Leukemia: A Report From the Children's Oncology Group. J Clin Oncol. 2020 07 20; 38(21):2398-2406. Getz KD, Sung L, Alonzo TA, Leger KJ, Gerbing RB, Pollard JA, Cooper T, Kolb EA, Gamis AS, Ky B, Aplenc R. PMID: 32343641; PMCID: PMC7367546.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    73. Genomic Variants of Cytarabine Sensitivity Associated with Treatment-Related Mortality in Pediatric AML: A Report from the Children's Oncology Group. Clin Cancer Res. 2020 06 15; 26(12):2891-2897. Phillips CL, Lane A, Gerbing RB, Alonzo TA, Wilkey A, Radloff G, Lange B, Gamazon ER, Dolan ME, Davies SM. PMID: 32122921; PMCID: PMC7722896.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    74. Bortezomib with standard chemotherapy for children with acute myeloid leukemia does not improve treatment outcomes: a report from the Children's Oncology Group. Haematologica. 2020 07; 105(7):1879-1886. Aplenc R, Meshinchi S, Sung L, Alonzo T, Choi J, Fisher B, Gerbing R, Hirsch B, Horton T, Kahwash S, Levine J, Loken M, Brodersen L, Pollard J, Raimondi S, Kolb EA, Gamis A. PMID: 32029509; PMCID: PMC7327649.
      View in: PubMed   Mentions: 76     Fields:    Translation:Humans
    75. A Phase 2 Trial of KIR-Mismatched Unrelated Donor Transplantation Using in Vivo T Cell Depletion with Antithymocyte Globulin in Acute Myelogenous Leukemia: Children's Oncology Group AAML05P1 Study. Biol Blood Marrow Transplant. 2020 04; 26(4):712-717. Davies SM, Iannone R, Alonzo TA, Wang YC, Gerbing R, Soni S, Kolb EA, Meshinchi S, Orchard PJ, Burns LJ, Shenoy S, Leung W. PMID: 31870931; PMCID: PMC7198330.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCellsCTClinical Trials
    76. Adaptive trial designs in diagnostic accuracy research. Stat Med. 2020 02 28; 39(5):591-601. Zapf A, Stark M, Gerke O, Ehret C, Benda N, Bossuyt P, Deeks J, Reitsma J, Alonzo T, Friede T. PMID: 31773788.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    77. The cost-effectiveness of human papillomavirus self-collection among cervical cancer screening non-attenders in El Salvador. Prev Med. 2020 02; 131:105931. Campos NG, Alfaro K, Maza M, Sy S, Melendez M, Masch R, Soler M, Conzuelo-Rodriguez G, Gage JC, Alonzo TA, Castle PE, Felix JC, Cremer M, Kim JJ. PMID: 31765712.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    78. Comprehensive Transcriptome Profiling of Cryptic CBFA2T3-GLIS2 Fusion-Positive AML Defines Novel Therapeutic Options: A COG and TARGET Pediatric AML Study. Clin Cancer Res. 2020 02 01; 26(3):726-737. Smith JL, Ries RE, Hylkema T, Alonzo TA, Gerbing RB, Santaguida MT, Eidenschink Brodersen L, Pardo L, Cummings CL, Loeb KR, Le Q, Imren S, Leonti AR, Gamis AS, Aplenc R, Kolb EA, Farrar JE, Triche TJ, Nguyen C, Meerzaman D, Loken MR, Oehler VG, Bolouri H, Meshinchi S. PMID: 31719049; PMCID: PMC7002196.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    79. Mixed-phenotype acute leukemia: A cohort and consensus research strategy from the Children's Oncology Group Acute Leukemia of Ambiguous Lineage Task Force. Cancer. 2020 02 01; 126(3):593-601. Orgel E, Alexander TB, Wood BL, Kahwash SB, Devidas M, Dai Y, Alonzo TA, Mullighan CG, Inaba H, Hunger SP, Raetz EA, Gamis AS, Rabin KR, Carroll AJ, Heerema NA, Berman JN, Woods WG, Loh ML, Zweidler-McKay PA, Horan JT, Children's Oncology Group Acute Leukemia of Ambiguous Lineage Task Force. PMID: 31661160; PMCID: PMC7489437.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    80. Trial Design Challenges and Approaches for Precision Oncology in Rare Tumors: Experiences of the Children's Oncology Group. JCO Precis Oncol. 2019; 3. Renfro LA, Ji L, Piao J, Onar-Thomas A, Kairalla JA, Alonzo TA. PMID: 32923863; PMCID: PMC7446492.
      View in: PubMed   Mentions: 15     Fields:    
    81. Pathologic Features of Down Syndrome Myelodysplastic Syndrome and Acute Myeloid Leukemia: A Report From the Children's Oncology Group Protocol AAML0431. Arch Pathol Lab Med. 2020 04; 144(4):466-472. Mast KJ, Taub JW, Alonzo TA, Gamis AS, Mosse CA, Mathew P, Berman JN, Wang YC, Jones HM, Campana D, Coustan-Smith E, Raimondi SC, Hirsch B, Hitzler JK, Head DR. PMID: 31429606; PMCID: PMC7031019.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    82. Deciphering the Significance of CD56 Expression in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group. Cytometry B Clin Cytom. 2020 01; 98(1):52-56. Pardo LM, Voigt AP, Alonzo TA, Wilson ER, Gerbing RB, Paine DJ, Dai F, Menssen AJ, Raimondi SC, Hirsch BA, Gamis AS, Meshinchi S, Wells DA, Brodersen LE, Loken MR. PMID: 31294507; PMCID: PMC7872511.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    83. Quality of life in pediatric acute myeloid leukemia: Report from the Children's Oncology Group. Cancer Med. 2019 08; 8(9):4454-4464. Nagarajan R, Gerbing R, Alonzo T, Johnston DL, Aplenc R, Kolb EA, Meshinchi S, Barakat LP, Sung L. PMID: 31190442; PMCID: PMC6675729.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    84. Functional Properties of KIT Mutations Are Associated with Differential Clinical Outcomes and Response to Targeted Therapeutics in CBF Acute Myeloid Leukemia. Clin Cancer Res. 2019 08 15; 25(16):5038-5048. Tarlock K, Alonzo TA, Wang YC, Gerbing RB, Ries R, Loken MR, Pardo L, Hylkema T, Joaquin J, Sarukkai L, Raimondi SC, Hirsch B, Sung L, Aplenc R, Bernstein I, Gamis AS, Meshinchi S, Pollard JA. PMID: 31182436; PMCID: PMC6754181.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCells
    85. CD33_PGx6_Score Predicts Gemtuzumab Ozogamicin Response in Childhood Acute Myeloid Leukemia: A Report From the Children's Oncology Group. JCO Precis Oncol. 2019; 3. Chauhan L, Shin M, Wang YC, Loken M, Pollard J, Aplenc R, Hirsch BA, Raimondi S, Ries RE, Bernstein ID, Gamis AS, Alonzo TA, Meshinchi S, Lamba JK. PMID: 32914031; PMCID: PMC7446480.
      View in: PubMed   Mentions: 10     Fields:    
    86. ABCB1 SNP predicts outcome in patients with acute myeloid leukemia treated with Gemtuzumab ozogamicin: a report from Children's Oncology Group AAML0531 Trial. Blood Cancer J. 2019 05 21; 9(6):51. Rafiee R, Chauhan L, Alonzo TA, Wang YC, Elmasry A, Loken MR, Pollard J, Aplenc R, Raimondi S, Hirsch BA, Bernstein ID, Gamis AS, Meshinchi S, Lamba JK. PMID: 31113932; PMCID: PMC6529443.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCTClinical Trials
    87. Evaluation of two alternative ablation treatments for cervical pre-cancer against standard gas-based cryotherapy: a randomized non-inferiority study. Int J Gynecol Cancer. 2019 May 03. Cremer M, Alfaro K, Garai J, Salinas M, Maza M, Zevallos A, Taxa L, Diaz AC, Castle P, Alonzo TA, Masch R, Soler M, Conzuelo-Rodriguez G, Gage JC, Felix JC. PMID: 31055452; PMCID: PMC9884482.
      View in: PubMed   Mentions: 3     Fields:    
    88. Evaluating the predictive value of measures of susceptibility to tobacco and alternative tobacco products. Addict Behav. 2019 09; 96:50-55. Barrington-Trimis JL, Liu F, Unger JB, Alonzo T, Cruz TB, Urman R, Pentz MA, Berhane K, McConnell R. PMID: 31035078; PMCID: PMC6579690.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    89. Development of acute lymphoblastic leukemia following treatment for acute myeloid leukemia in children with Down syndrome: A case report and retrospective review of Children's Oncology Group acute myeloid leukemia trials. Pediatr Blood Cancer. 2019 08; 66(8):e27700. Murphy BR, Roth M, Kolb EA, Alonzo T, Gerbing R, Wells RJ. PMID: 30908863; PMCID: PMC6941434.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    90. Publisher Correction: The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions. Nat Med. 2019 Mar; 25(3):530. Bolouri H, Farrar JE, Triche T, Ries RE, Lim EL, Alonzo TA, Ma Y, Moore R, Mungall AJ, Marra MA, Zhang J, Ma X, Liu Y, Liu Y, Auvil JMG, Davidsen TM, Gesuwan P, Hermida LC, Salhia B, Capone S, Ramsingh G, Zwaan CM, Noort S, Piccolo SR, Kolb EA, Gamis AS, Smith MA, Gerhard DS, Meshinchi S. PMID: 30705421; PMCID: PMC7747938.
      View in: PubMed   Mentions: 5     Fields:    
    91. Genetic mechanisms of primary chemotherapy resistance in pediatric acute myeloid leukemia. Leukemia. 2019 08; 33(8):1934-1943. McNeer NA, Philip J, Geiger H, Ries RE, Lavallée VP, Walsh M, Shah M, Arora K, Emde AK, Robine N, Alonzo TA, Kolb EA, Gamis AS, Smith M, Gerhard DS, Guidry-Auvil J, Meshinchi S, Kentsis A. PMID: 30760869; PMCID: PMC6687545.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    92. Comparisons of New HIV Rapid Test Kit Performance. AIDS Behav. 2019 Feb; 23(2):313-317. Fisher DG, Hess KL, Reynolds GL, Alonzo TA, Huckabay LM, Van Otterloo L, Hosmer DW. PMID: 29943123; PMCID: PMC6309759.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    93. Risk Markers for Significant Bleeding and Thrombosis in Pediatric Acute Promyelocytic Leukemia; Report From the Children's Oncology Group Study AAML0631. J Pediatr Hematol Oncol. 2019 01; 41(1):51-55. Rajpurkar M, Alonzo TA, Wang YC, Gerbing RB, Gamis AS, Feusner JH, Gregory J, Kutny MA. PMID: 30095694; PMCID: PMC6419515.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    94. The Children's Oncology Group: Organizational Structure, Membership, and Institutional Characteristics. J Pediatr Oncol Nurs. 2019 Jan/Feb; 36(1):24-34. Withycombe JS, Alonzo TA, Wilkins-Sanchez MA, Hetherington M, Adamson PC, Landier W. PMID: 30426816; PMCID: PMC6389409.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    95. Occurrence of Treatment-Related Cardiotoxicity and Its Impact on Outcomes Among Children Treated in the AAML0531 Clinical Trial: A Report From the Children's Oncology Group. J Clin Oncol. 2019 01 01; 37(1):12-21. Getz KD, Sung L, Ky B, Gerbing RB, Leger KJ, Leahy AB, Sack L, Woods WG, Alonzo T, Gamis A, Aplenc R. PMID: 30379624; PMCID: PMC6354770.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCTClinical Trials
    96. Prognostic impact of t(16;21)(p11;q22) and t(16;21)(q24;q22) in pediatric AML: a retrospective study by the I-BFM Study Group. Blood. 2018 10 11; 132(15):1584-1592. Noort S, Zimmermann M, Reinhardt D, Cuccuini W, Pigazzi M, Smith J, Ries RE, Alonzo TA, Hirsch B, Tomizawa D, Locatelli F, Gruber TA, Raimondi S, Sonneveld E, Cheuk DK, Dworzak M, Stary J, Abrahamsson J, Arad-Cohen N, Czogala M, De Moerloose B, Hasle H, Meshinchi S, van den Heuvel-Eibrink M, Zwaan CM. PMID: 30150206; PMCID: PMC6265640.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    97. Acceptability of self-sampling and human papillomavirus testing among non-attenders of cervical cancer screening programs in El Salvador. Prev Med. 2018 09; 114:149-155. Maza M, Melendez M, Masch R, Alfaro K, Chacon A, Gonzalez E, Soler M, Conzuelo-Rodriguez G, Gage JC, Alonzo TA, Castle PE, Felix JC, Cremer M. PMID: 29958860.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCellsPHPublic Health
    98. Erratum: The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions. Nat Med. 2018 Apr 10; 24(4):526. Bolouri H, Farrar JE, Triche T, Ries RE, Lim EL, Alonzo TA, Ma Y, Moore R, Mungall AJ, Marra MA, Zhang J, Ma X, Liu Y, Liu Y, Auvil JMG, Davidsen TM, Gesuwan P, Hermida LC, Salhia B, Capone S, Ramsingh G, Zwaan CM, Noort S, Piccolo SR, Kolb EA, Gamis AS, Smith MA, Gerhard DS, Meshinchi S. PMID: 29634680.
      View in: PubMed   Mentions: 2     Fields:    
    99. Estimation of the volume under the receiver-operating characteristic surface adjusting for non-ignorable verification bias. Stat Methods Med Res. 2018 03; 27(3):715-739. Zhang Y, Alonzo TA, Alzheimer’s Disease Neuroimaging Initiative. PMID: 29338546.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    100. Effects of Maintenance on Quality of Performance of Cryotherapy Devices for Treatment of Precancerous Cervical Lesions. J Low Genit Tract Dis. 2018 01; 22(1):47-51. Maza M, Figueroa R, Laskow B, Juárez A, Alfaro K, Alonzo TA, Felix JC, Gage JC, Cremer M. PMID: 29271857.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    101. Depth of Cervical Intraepithelial Neoplasia Grade 3 in Peruvian Women: Implications for Therapeutic Depth of Necrosis. J Low Genit Tract Dis. 2018 Jan; 22(1):27-30. Taxa L, Jeronimo J, Alonzo TA, Gage J, Castle PE, Cremer ML, Felix JC. PMID: 29271853; PMCID: PMC5745048.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    102. The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions. Nat Med. 2018 01; 24(1):103-112. Bolouri H, Farrar JE, Triche T, Ries RE, Lim EL, Alonzo TA, Ma Y, Moore R, Mungall AJ, Marra MA, Zhang J, Ma X, Liu Y, Liu Y, Auvil JMG, Davidsen TM, Gesuwan P, Hermida LC, Salhia B, Capone S, Ramsingh G, Zwaan CM, Noort S, Piccolo SR, Kolb EA, Gamis AS, Smith MA, Gerhard DS, Meshinchi S. PMID: 29227476; PMCID: PMC5907936.
      View in: PubMed   Mentions: 362     Fields:    Translation:HumansCells
    103. MicroRNA Expression-Based Model Indicates Event-Free Survival in Pediatric Acute Myeloid Leukemia. J Clin Oncol. 2017 Dec 10; 35(35):3964-3977. Lim EL, Trinh DL, Ries RE, Wang J, Gerbing RB, Ma Y, Topham J, Hughes M, Pleasance E, Mungall AJ, Moore R, Zhao Y, Aplenc R, Sung L, Kolb EA, Gamis A, Smith M, Gerhard DS, Alonzo TA, Meshinchi S, Marra MA. PMID: 29068783; PMCID: PMC5721230.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    104. Distinct signaling events promote resistance to mitoxantrone and etoposide in pediatric AML: a Children's Oncology Group report. Oncotarget. 2017 Oct 27; 8(52):90037-90049. Long X, Gerbing RB, Alonzo TA, Redell MS. PMID: 29163809; PMCID: PMC5685730.
      View in: PubMed   Mentions: 2     Fields:    
    105. Phenotype in combination with genotype improves outcome prediction in acute myeloid leukemia: a report from Children's Oncology Group protocol AAML0531. Haematologica. 2017 12; 102(12):2058-2068. Voigt AP, Brodersen LE, Alonzo TA, Gerbing RB, Menssen AJ, Wilson ER, Kahwash S, Raimondi SC, Hirsch BA, Gamis AS, Meshinchi S, Wells DA, Loken MR. PMID: 28883080; PMCID: PMC5709105.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    106. Performance of cigarette susceptibility index among e-cigarette and hookah users. Drug Alcohol Depend. 2018 02 01; 183:43-50. Barrington-Trimis JL, Leventhal AM, Alonzo TA, Cruz TB, Urman R, Liu F, Pentz MA, Unger JB, McConnell R. PMID: 29223916; PMCID: PMC5803381.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    107. Arsenic Trioxide Consolidation Allows Anthracycline Dose Reduction for Pediatric Patients With Acute Promyelocytic Leukemia: Report From the Children's Oncology Group Phase III Historically Controlled Trial AAML0631. J Clin Oncol. 2017 Sep 10; 35(26):3021-3029. Kutny MA, Alonzo TA, Gerbing RB, Wang YC, Raimondi SC, Hirsch BA, Fu CH, Meshinchi S, Gamis AS, Feusner JH, Gregory JJ. PMID: 28767288; PMCID: PMC5590801.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansCTClinical Trials
    108. Gemtuzumab ozogamicin in infants with AML: results from the Children's Oncology Group trials AAML03P1 and AAML0531. Blood. 2017 08 17; 130(7):943-945. Guest EM, Aplenc R, Sung L, Raimondi SC, Hirsch BA, Alonzo TA, Gerbing RB, Wang YJ, Kahwash SB, Heerema-McKenney A, Meshinchi S, Gamis AS. PMID: 28674028; PMCID: PMC5561899.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    109. CD33 Splicing Polymorphism Determines Gemtuzumab Ozogamicin Response in De Novo Acute Myeloid Leukemia: Report From Randomized Phase III Children's Oncology Group Trial AAML0531. J Clin Oncol. 2017 Aug 10; 35(23):2674-2682. Lamba JK, Chauhan L, Shin M, Loken MR, Pollard JA, Wang YC, Ries RE, Aplenc R, Hirsch BA, Raimondi SC, Walter RB, Bernstein ID, Gamis AS, Alonzo TA, Meshinchi S. PMID: 28644774; PMCID: PMC5549451.
      View in: PubMed   Mentions: 81     Fields:    Translation:HumansCTClinical Trials
    110. Center-level variation in accuracy of adverse event reporting in a clinical trial for pediatric acute myeloid leukemia: a report from the Children's Oncology Group. Haematologica. 2017 09; 102(9):e340-e343. Miller TP, Li Y, Kavcic M, Getz KD, Huang YV, Sung L, Alonzo TA, Gerbing R, Daves MH, Horton TM, Pulsipher MA, Pollard J, Bagatell R, Seif AE, Fisher BT, Luger S, Gamis AS, Adamson PC, Aplenc R. PMID: 28642300; PMCID: PMC5685242.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    111. Central nervous system disease in pediatric acute myeloid leukemia: A report from the Children's Oncology Group. Pediatr Blood Cancer. 2017 Dec; 64(12). Johnston DL, Alonzo TA, Gerbing RB, Aplenc R, Woods WG, Meshinchi S, Gamis AS. PMID: 28453910; PMCID: PMC5647219.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    112. Population Pharmacokinetic Analysis of Bortezomib in Pediatric Leukemia Patients: Model-Based Support for Body Surface Area-Based Dosing Over the 2- to 16-Year Age Range. J Clin Pharmacol. 2017 09; 57(9):1183-1193. Hanley MJ, Mould DR, Taylor TJ, Gupta N, Suryanarayan K, Neuwirth R, Esseltine DL, Horton TM, Aplenc R, Alonzo TA, Lu X, Milton A, Venkatakrishnan K. PMID: 28419486; PMCID: PMC5561493.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    113. Genomic architecture and treatment outcome in pediatric acute myeloid leukemia: a Children's Oncology Group report. Blood. 2017 06 08; 129(23):3051-3058. Vujkovic M, Attiyeh EF, Ries RE, Goodman EK, Ding Y, Kavcic M, Alonzo TA, Wang YC, Gerbing RB, Sung L, Hirsch B, Raimondi S, Gamis AS, Meshinchi S, Aplenc R. PMID: 28411282; PMCID: PMC5465840.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    114. Improved outcomes for myeloid leukemia of Down syndrome: a report from the Children's Oncology Group AAML0431 trial. Blood. 2017 06 22; 129(25):3304-3313. Taub JW, Berman JN, Hitzler JK, Sorrell AD, Lacayo NJ, Mast K, Head D, Raimondi S, Hirsch B, Ge Y, Gerbing RB, Wang YC, Alonzo TA, Campana D, Coustan-Smith E, Mathew P, Gamis AS. PMID: 28389462; PMCID: PMC5482102.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCTClinical Trials
    115. Disease Characteristics and Prognostic Implications of Cell-Surface FLT3 Receptor (CD135) Expression in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group. Clin Cancer Res. 2017 Jul 15; 23(14):3649-3656. Tarlock K, Alonzo TA, Loken MR, Gerbing RB, Ries RE, Aplenc R, Sung L, Raimondi SC, Hirsch BA, Kahwash SB, McKenney A, Kolb EA, Gamis AS, Meshinchi S. PMID: 28108543; PMCID: PMC5511553.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    116. Erratum to: High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group. J Hematol Oncol. 2016 11 30; 9(1):133. Laszlo GS, Alonzo TA, Gudgeon CJ, Harrington KH, Kentsis A, Gerbing RB, Wang YC, Ries RE, Raimondi SC, Hirsch BA, Gamis AS, Meshinchi S, Walter RB. PMID: 27903291; PMCID: PMC5129595.
      View in: PubMed   Mentions: 5     Fields:    
    117. Shorter Remission Telomere Length Predicts Delayed Neutrophil Recovery After Acute Myeloid Leukemia Therapy: A Report From the Children's Oncology Group. J Clin Oncol. 2016 11 01; 34(31):3766-3772. Gerbing RB, Alonzo TA, Sung L, Gamis AS, Meshinchi S, Plon SE, Bertuch AA, Gramatges MM. PMID: 27354474; PMCID: PMC5446304.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    118. Genomics of primary chemoresistance and remission induction failure in paediatric and adult acute myeloid leukaemia. Br J Haematol. 2017 Jan; 176(1):86-91. Brown FC, Cifani P, Drill E, He J, Still E, Zhong S, Balasubramanian S, Pavlick D, Yilmazel B, Knapp KM, Alonzo TA, Meshinchi S, Stone RM, Kornblau SM, Marcucci G, Gamis AS, Byrd JC, Gonen M, Levine RL, Kentsis A. PMID: 27766616; PMCID: PMC5177472.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    119. Proteasome subunit expression analysis and chemosensitivity in relapsed paediatric acute leukaemia patients receiving bortezomib-containing chemotherapy. J Hematol Oncol. 2016 09 06; 9(1):82. Niewerth D, Kaspers GJ, Jansen G, van Meerloo J, Zweegman S, Jenkins G, Whitlock JA, Hunger SP, Lu X, Alonzo TA, van de Ven PM, Horton TM, Cloos J. PMID: 27599459; PMCID: PMC5011854.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCTClinical Trials
    120. miR-155 expression and correlation with clinical outcome in pediatric AML: A report from Children's Oncology Group. Pediatr Blood Cancer. 2016 12; 63(12):2096-2103. Ramamurthy R, Hughes M, Morris V, Bolouri H, Gerbing RB, Wang YC, Loken MR, Raimondi SC, Hirsch BA, Gamis AS, Oehler VG, Alonzo TA, Meshinchi S. PMID: 27511899; PMCID: PMC5497493.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    121. Comparing Analytic Methods for Longitudinal GWAS and a Case-Study Evaluating Chemotherapy Course Length in Pediatric AML. A Report from the Children's Oncology Group. Front Genet. 2016; 7:139. Vujkovic M, Aplenc R, Alonzo TA, Gamis AS, Li Y. PMID: 27547214; PMCID: PMC4974249.
      View in: PubMed   Mentions: 2  
    122. Early discharge as a mediator of greater ICU-level care requirements in patients not enrolled on the AAML0531 clinical trial: a Children's Oncology Group report. Cancer Med. 2016 09; 5(9):2412-6. Getz KD, Miller TP, Seif AE, Li Y, Huang YS, Alonzo T, Gerbing R, Sung L, Hall M, Bagatell R, Gamis A, Fisher BT, Aplenc R. PMID: 27474232; PMCID: PMC5055162.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    123. Association between prolonged neutropenia and reduced relapse risk in pediatric AML: A report from the children's oncology group. Int J Cancer. 2016 Nov 01; 139(9):1930-5. Sung L, Aplenc R, Alonzo TA, Gerbing RB, Wang YC, Meshinchi S, Gamis AS. PMID: 27312107; PMCID: PMC4990479.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    124. Inverse probability weighting estimation of the volume under the ROC surface in the presence of verification bias. Biom J. 2016 Nov; 58(6):1338-1356. Zhang Y, Alonzo TA, Alzheimer's Disease Neuroimaging Initiative. PMID: 27338713.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    125. CSF3R mutations have a high degree of overlap with CEBPA mutations in pediatric AML. Blood. 2016 06 16; 127(24):3094-8. Maxson JE, Ries RE, Wang YC, Gerbing RB, Kolb EA, Thompson SL, Guidry Auvil JM, Marra MA, Ma Y, Zong Z, Mungall AJ, Moore R, Long W, Gesuwan P, Davidsen TM, Hermida LC, Hughes SB, Farrar JE, Radich JP, Smith MA, Gerhard DS, Gamis AS, Alonzo TA, Meshinchi S. PMID: 27143256; PMCID: PMC4911865.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    126. A recurrent immunophenotype at diagnosis independently identifies high-risk pediatric acute myeloid leukemia: a report from Children's Oncology Group. Leukemia. 2016 10; 30(10):2077-2080. Eidenschink Brodersen L, Alonzo TA, Menssen AJ, Gerbing RB, Pardo L, Voigt AP, Kahwash SB, Hirsch B, Raimondi S, Gamis AS, Meshinchi S, Loken MR. PMID: 27133823; PMCID: PMC5136463.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    127. Recurrent abnormalities can be used for risk group stratification in pediatric AMKL: a retrospective intergroup study. Blood. 2016 06 30; 127(26):3424-30. de Rooij JD, Masetti R, van den Heuvel-Eibrink MM, Cayuela JM, Trka J, Reinhardt D, Rasche M, Sonneveld E, Alonzo TA, Fornerod M, Zimmermann M, Pigazzi M, Pieters R, Meshinchi S, Zwaan CM, Locatelli F. PMID: 27114462; PMCID: PMC5161011.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansCells
    128. Introducing a High-Risk HPV DNA Test Into a Public Sector Screening Program in El Salvador. J Low Genit Tract Dis. 2016 Apr; 20(2):145-50. Cremer ML, Maza M, Alfaro KM, Kim JJ, Ditzian LR, Villalta S, Alonzo TA, Felix JC, Castle PE, Gage JC. PMID: 26890683; PMCID: PMC4819528.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    129. Genomic Profiling of Pediatric Acute Myeloid Leukemia Reveals a Changing Mutational Landscape from Disease Diagnosis to Relapse. Cancer Res. 2016 04 15; 76(8):2197-205. Farrar JE, Schuback HL, Ries RE, Wai D, Hampton OA, Trevino LR, Alonzo TA, Guidry Auvil JM, Davidsen TM, Gesuwan P, Hermida L, Muzny DM, Dewal N, Rustagi N, Lewis LR, Gamis AS, Wheeler DA, Smith MA, Gerhard DS, Meshinchi S. PMID: 26941285; PMCID: PMC4873364.
      View in: PubMed   Mentions: 87     Fields:    Translation:Humans
    130. Accuracy of Adverse Event Ascertainment in Clinical Trials for Pediatric Acute Myeloid Leukemia. J Clin Oncol. 2016 05 01; 34(13):1537-43. Miller TP, Li Y, Kavcic M, Troxel AB, Huang YS, Sung L, Alonzo TA, Gerbing R, Hall M, Daves MH, Horton TM, Pulsipher MA, Pollard JA, Bagatell R, Seif AE, Fisher BT, Luger S, Gamis AS, Adamson PC, Aplenc R. PMID: 26884558; PMCID: PMC4872308.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    131. CD33 Expression and Its Association With Gemtuzumab Ozogamicin Response: Results From the Randomized Phase III Children's Oncology Group Trial AAML0531. J Clin Oncol. 2016 Mar 01; 34(7):747-55. Pollard JA, Loken M, Gerbing RB, Raimondi SC, Hirsch BA, Aplenc R, Bernstein ID, Gamis AS, Alonzo TA, Meshinchi S. PMID: 26786921; PMCID: PMC4872025.
      View in: PubMed   Mentions: 73     Fields:    Translation:HumansCTClinical Trials
    132. A comparison of discharge strategies after chemotherapy completion in pediatric patients with acute myeloid leukemia: a report from the Children's Oncology Group. Leuk Lymphoma. 2016 07; 57(7):1567-74. Miller TP, Getz KD, Kavcic M, Li Y, Huang YS, Sung L, Alonzo TA, Gerbing R, Daves M, Horton TM, Pulsipher MA, Pollard J, Bagatell R, Seif AE, Fisher BT, Gamis AS, Aplenc R. PMID: 26727639; PMCID: PMC4899280.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    133. Corrigendum: The genomic landscape of juvenile myelomonocytic leukemia. Nat Genet. 2016 Jan; 48(1):101. Stieglitz E, Taylor-Weiner AN, Chang TY, Gelston LC, Wang YD, Mazor T, Esquivel E, Yu A, Seepo S, Olsen SR, Rosenberg M, Archambeault SL, Abusin G, Beckman K, Brown PA, Briones M, Carcamo B, Cooper T, Dahl GV, Emanuel PD, Fluchel MN, Goyal RK, Hayashi RJ, Hitzler J, Hugge C, Liu YL, Messinger YH, Mahoney DH, Monteleone P, Nemecek ER, Roehrs PA, Schore RJ, Stine KC, Takemoto CM, Toretsky JA, Costello JF, Olshen AB, Stewart C, Li Y, Ma J, Gerbing RB, Alonzo TA, Getz G, Gruber TA, Golub TR, Stegmaier K, Loh ML. PMID: 26711114.
      View in: PubMed   Mentions: 2     Fields:    
    134. Gemtuzumab Ozogamicin Reduces Relapse Risk in FLT3/ITD Acute Myeloid Leukemia: A Report from the Children's Oncology Group. Clin Cancer Res. 2016 Apr 15; 22(8):1951-7. Tarlock K, Alonzo TA, Gerbing RB, Raimondi SC, Hirsch BA, Sung L, Pollard JA, Aplenc R, Loken MR, Gamis AS, Meshinchi S. PMID: 26644412; PMCID: PMC4834220.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCTClinical Trials
    135. Merging Children's Oncology Group Data with an External Administrative Database Using Indirect Patient Identifiers: A Report from the Children's Oncology Group. PLoS One. 2015; 10(11):e0143480. Li Y, Hall M, Fisher BT, Seif AE, Huang YS, Bagatell R, Getz KD, Alonzo TA, Gerbing RB, Sung L, Adamson PC, Gamis A, Aplenc R. PMID: 26606521; PMCID: PMC4659568.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    136. Clinical Impact of Additional Cytogenetic Aberrations, cKIT and RAS Mutations, and Treatment Elements in Pediatric t(8;21)-AML: Results From an International Retrospective Study by the International Berlin-Frankfurt-Münster Study Group. J Clin Oncol. 2015 Dec 20; 33(36):4247-58. Klein K, Kaspers G, Harrison CJ, Beverloo HB, Reedijk A, Bongers M, Cloos J, Pession A, Reinhardt D, Zimmerman M, Creutzig U, Dworzak M, Alonzo T, Johnston D, Hirsch B, Zapotocky M, De Moerloose B, Fynn A, Lee V, Taga T, Tawa A, Auvrignon A, Zeller B, Forestier E, Salgado C, Balwierz W, Popa A, Rubnitz J, Raimondi S, Gibson B. PMID: 26573082; PMCID: PMC5321085.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansCells
    137. High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group. J Hematol Oncol. 2015 10 20; 8:115. Laszlo GS, Alonzo TA, Gudgeon CJ, Harrington KH, Kentsis A, Gerbing RB, Wang YC, Ries RE, Raimondi SC, Hirsch BA, Gamis AS, Meshinchi S, Walter RB. PMID: 26487643; PMCID: PMC4618184.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCTClinical Trials
    138. The genomic landscape of juvenile myelomonocytic leukemia. Nat Genet. 2015 Nov; 47(11):1326-1333. Stieglitz E, Taylor-Weiner AN, Chang TY, Gelston LC, Wang YD, Mazor T, Esquivel E, Yu A, Seepo S, Olsen S, Rosenberg M, Archambeault SL, Abusin G, Beckman K, Brown PA, Briones M, Carcamo B, Cooper T, Dahl GV, Emanuel PD, Fluchel MN, Goyal RK, Hayashi RJ, Hitzler J, Hugge C, Liu YL, Messinger YH, Mahoney DH, Monteleone P, Nemecek ER, Roehrs PA, Schore RJ, Stine KC, Takemoto CM, Toretsky JA, Costello JF, Olshen AB, Stewart C, Li Y, Ma J, Gerbing RB, Alonzo TA, Getz G, Gruber T, Golub T, Stegmaier K, Loh ML. PMID: 26457647; PMCID: PMC4626387.
      View in: PubMed   Mentions: 124     Fields:    Translation:HumansCells
    139. Ligand-induced STAT3 signaling increases at relapse and is associated with outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group. Haematologica. 2015 Dec; 100(12):e496-500. Stevens AM, Ruiz MJ, Gerbing RB, Alonzo TA, Gamis AS, Redell MS. PMID: 26294728; PMCID: PMC4666340.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    140. Comparison of Rapid Point-of-Care Tests for Detection of Antibodies to Hepatitis C Virus. Open Forum Infect Dis. 2015 Sep; 2(3):ofv101. Fisher DG, Hess KL, Erlyana E, Reynolds GL, Cummins CA, Alonzo TA. PMID: 26269795; PMCID: PMC4531224.
      View in: PubMed   Mentions: 9  
    141. Ethnic variation of TET2 SNP rs2454206 and association with clinical outcome in childhood AML: a report from the Children's Oncology Group. Leukemia. 2015 Dec; 29(12):2424-6. Kutny MA, Alonzo TA, Gamazon ER, Gerbing RB, Geraghty D, Lange B, Heerema NA, Sung L, Aplenc R, Franklin J, Raimondi SC, Hirsch BA, Konkashbaev A, Cox NJ, Onel K, Gamis AS, Meshinchi S. PMID: 26126966; PMCID: PMC4675677.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    142. Concordance of copy number alterations using a common analytic pipeline for genome-wide analysis of Illumina and Affymetrix genotyping data: a report from the Children's Oncology Group. Cancer Genet. 2015 Jul-Aug; 208(7-8):408-13. Vujkovic M, Attiyeh EF, Ries RE, Horn M, Goodman EK, Ding Y, Kavcic M, Alonzo TA, Gerbing RB, Hirsch B, Raimondi S, Gamis AS, Meshinchi S, Aplenc R. PMID: 26163103; PMCID: PMC4523450.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    143. Comparison of in-patient costs for children treated on the AAML0531 clinical trial: A report from the Children's Oncology Group. Pediatr Blood Cancer. 2015 Oct; 62(10):1775-81. Getz KD, Li Y, Alonzo TA, Hall M, Gerbing RB, Sung L, Huang YS, Arnold S, Seif AE, Miller TP, Bagatell R, Fisher BT, Adamson PC, Gamis A, Keren R, Aplenc R. PMID: 25946708; PMCID: PMC4546551.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    144. Patient-Reported Outcome Coordinator Did Not Improve Quality of Life Assessment Response Rates: A Report from the Children's Oncology Group. PLoS One. 2015; 10(4):e0125290. Johnston D, Gerbing R, Alonzo T, Aplenc R, Nagarajan R, Schulte F, Cullen P, Sung L. PMID: 25915772; PMCID: PMC4411136.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    145. Multimerin-1 (MMRN1) as Novel Adverse Marker in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group. Clin Cancer Res. 2015 Jul 15; 21(14):3187-95. Laszlo GS, Alonzo TA, Gudgeon CJ, Harrington KH, Gerbing RB, Wang YC, Ries RE, Raimondi SC, Hirsch BA, Gamis AS, Meshinchi S, Walter RB. PMID: 25825478; PMCID: PMC4506237.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    146. Comparison of administrative/billing data to expected protocol-mandated chemotherapy exposure in children with acute myeloid leukemia: A report from the Children's Oncology Group. Pediatr Blood Cancer. 2015 Jul; 62(7):1184-9. Miller TP, Troxel AB, Li Y, Huang YS, Alonzo TA, Gerbing RB, Hall M, Torp K, Fisher BT, Bagatell R, Seif AE, Sung L, Gamis A, Rubin D, Luger S, Aplenc R. PMID: 25760019; PMCID: PMC4433587.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    147. Phase II/III trial of a pre-transplant farnesyl transferase inhibitor in juvenile myelomonocytic leukemia: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2015 Apr; 62(4):629-36. Stieglitz E, Ward AF, Gerbing RB, Alonzo TA, Arceci RJ, Liu YL, Emanuel PD, Widemann BC, Cheng JW, Jayaprakash N, Balis FM, Castleberry RP, Bunin NJ, Loh ML, Cooper TM. PMID: 25704135; PMCID: PMC4339233.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCTClinical Trials
    148. Subclonal mutations in SETBP1 confer a poor prognosis in juvenile myelomonocytic leukemia. Blood. 2015 Jan 15; 125(3):516-24. Stieglitz E, Troup CB, Gelston LC, Haliburton J, Chow ED, Yu KB, Akutagawa J, Taylor-Weiner AN, Liu YL, Wang YD, Beckman K, Emanuel PD, Braun BS, Abate A, Gerbing RB, Alonzo TA, Loh ML. PMID: 25395418; PMCID: PMC4296011.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    149. Gemtuzumab ozogamicin in children and adolescents with de novo acute myeloid leukemia improves event-free survival by reducing relapse risk: results from the randomized phase III Children’s Oncology Group trial AAML0531. J Clin Oncol. 2014 Sep 20; 32(27):3021-32. Gamis AS, Alonzo TA, Meshinchi S, Sung L, Gerbing RB, Raimondi SC, Hirsch BA, Kahwash SB, Heerema-McKenney A, Winter L, Glick K, Davies SM, Byron P, Smith FO, Aplenc R. PMID: 25092781; PMCID: PMC4162498.
      View in: PubMed   Mentions: 222     Fields:    Translation:HumansCTClinical Trials
    150. NUP98/NSD1 and FLT3/ITD coexpression is more prevalent in younger AML patients and leads to induction failure: a COG and SWOG report. Blood. 2014 Oct 09; 124(15):2400-7. Ostronoff F, Othus M, Gerbing RB, Loken MR, Raimondi SC, Hirsch BA, Lange BJ, Petersdorf S, Radich J, Appelbaum FR, Gamis AS, Alonzo TA, Meshinchi S. PMID: 25145343; PMCID: PMC4192751.
      View in: PubMed   Mentions: 51     Fields:    Translation:Humans
    151. A Phase 2 study of bortezomib combined with either idarubicin/cytarabine or cytarabine/etoposide in children with relapsed, refractory or secondary acute myeloid leukemia: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2014 Oct; 61(10):1754-60. Horton TM, Perentesis JP, Gamis AS, Alonzo TA, Gerbing RB, Ballard J, Adlard K, Howard DS, Smith FO, Jenkins G, Kelder A, Schuurhuis GJ, Moscow JA. PMID: 24976003; PMCID: PMC4247259.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansAnimalsCTClinical Trials
    152. AAML0523: a report from the Children's Oncology Group on the efficacy of clofarabine in combination with cytarabine in pediatric patients with recurrent acute myeloid leukemia. Cancer. 2014 Aug 15; 120(16):2482-9. Cooper TM, Alonzo TA, Gerbing RB, Perentesis JP, Whitlock JA, Taub JW, Horton TM, Gamis AS, Meshinchi S, Loken MR, Razzouk BI. PMID: 24771494; PMCID: PMC4126862.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCTClinical Trials
    153. Acute myeloid leukaemia (AML) with t(6;9)(p23;q34) is associated with poor outcome in childhood AML regardless of FLT3-ITD status: a report from the Children's Oncology Group. Br J Haematol. 2014 Jul; 166(2):254-259. Tarlock K, Alonzo TA, Moraleda PP, Gerbing RB, Raimondi SC, Hirsch BA, Ravindranath Y, Lange B, Woods WG, Gamis AS, Meshinchi S. PMID: 24661089; PMCID: PMC4079767.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCellsCTClinical Trials
    154. High expression of suppressor of cytokine signaling-2 predicts poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group. Leuk Lymphoma. 2014 Dec; 55(12):2817-21. Laszlo GS, Ries RE, Gudgeon CJ, Harrington KH, Alonzo TA, Gerbing RB, Raimondi SC, Hirsch BA, Gamis AS, Meshinchi S, Walter RB. PMID: 24559289; PMCID: PMC4285350.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    155. Reducing decision errors in the paired comparison of the diagnostic accuracy of screening tests with Gaussian outcomes. BMC Med Res Methodol. 2014 Mar 05; 14:37. Ringham BM, Alonzo TA, Brinton JT, Kreidler SM, Munjal A, Muller KE, Glueck DH. PMID: 24597517; PMCID: PMC4015908.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    156. Gene expression profiling to predict viridans group streptococcal and invasive fungal infection in pediatric acute myeloid leukemia: a brief report from the Children's Oncology Group. Acta Haematol. 2014; 131(3):167-9. Lee GE, Sung L, Fisher BT, Sullivan KE, McWilliams T, Tobias JW, Meshinchi S, Alonzo TA, Gamis A, Aplenc R. PMID: 24217778; PMCID: PMC4443693.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    157. BIRC5 (survivin) splice variant expression correlates with refractory disease and poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2014 Apr; 61(4):647-52. Moore AS, Alonzo TA, Gerbing RB, Lange BJ, Heerema NA, Franklin J, Raimondi SC, Hirsch BA, Gamis AS, Meshinchi S. PMID: 24127439; PMCID: PMC4285339.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    158. Accuracy of a home-based device for giving an early estimate of pregnancy duration compared with reference methods. Fertil Steril. 2013 Dec; 100(6):1635-41.e1. Johnson SR, Godbert S, Perry P, Parsons P, Roberts L, Buchanan P, Larsen J, Alonzo TA, Zinaman M. PMID: 24074759.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    159. Outcome of adolescents and young adults with acute myeloid leukemia treated on COG trials compared to CALGB and SWOG trials. Cancer. 2013 Dec 01; 119(23):4170-9. Woods WG, Franklin AR, Alonzo TA, Gerbing RB, Donohue KA, Othus M, Horan J, Appelbaum FR, Estey EH, Bloomfield CD, Larson RA. PMID: 24104597; PMCID: PMC3833872.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    160. Differences in outcomes of newly diagnosed acute myeloid leukemia for adolescent/young adult and younger patients: a report from the Children's Oncology Group. Cancer. 2013 Dec 01; 119(23):4162-9. Canner J, Alonzo TA, Franklin J, Freyer DR, Gamis A, Gerbing RB, Lange BJ, Meshinchi S, Woods WG, Perentesis J, Horan J. PMID: 24104395; PMCID: PMC4398142.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    161. Outcome of pediatric patients with acute myeloid leukemia (AML) and -5/5q- abnormalities from five pediatric AML treatment protocols: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2013 Dec; 60(12):2073-8. Johnston DL, Alonzo TA, Gerbing RB, Hirsch B, Heerema NA, Ravindranath Y, Woods WG, Lange BJ, Gamis AS, Raimondi SC. PMID: 24039149.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    162. Pediatric acute myeloid leukemia with t(8;16)(p11;p13), a distinct clinical and biological entity: a collaborative study by the International-Berlin-Frankfurt-Munster AML-study group. Blood. 2013 Oct 10; 122(15):2704-13. Coenen EA, Zwaan CM, Reinhardt D, Harrison CJ, Haas OA, de Haas V, Mihál V, De Moerloose B, Jeison M, Rubnitz JE, Tomizawa D, Johnston D, Alonzo TA, Hasle H, Auvrignon A, Dworzak M, Pession A, van der Velden VH, Swansbury J, Wong KF, Terui K, Savasan S, Winstanley M, Vaitkeviciene G, Zimmermann M, Pieters R, van den Heuvel-Eibrink MM. PMID: 23974201; PMCID: PMC4314534.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCells
    163. Comparable survival for pediatric acute myeloid leukemia with poor-risk cytogenetics following chemotherapy, matched related donor, or unrelated donor transplantation. Pediatr Blood Cancer. 2014 Feb; 61(2):269-75. Kelly MJ, Horan JT, Alonzo TA, Eapen M, Gerbing RB, He W, Lange BJ, Parsons SK, Woods WG. PMID: 23955900; PMCID: PMC3919967.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    164. The prognostic effect of high diagnostic WT1 gene expression in pediatric AML depends on WT1 SNP rs16754 status: report from the Children's Oncology Group. Pediatr Blood Cancer. 2014 Jan; 61(1):81-8. Ho PA, Alonzo TA, Gerbing RB, Kuhn J, Pollard JA, Hirsch B, Raimondi SC, Gamis AS, Meshinchi S. PMID: 23956224.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    165. High EVI1 expression is associated with MLL rearrangements and predicts decreased survival in paediatric acute myeloid leukaemia: a report from the children's oncology group. Br J Haematol. 2013 Sep; 162(5):670-7. Ho PA, Alonzo TA, Gerbing RB, Pollard JA, Hirsch B, Raimondi SC, Cooper T, Gamis AS, Meshinchi S. PMID: 23826732; PMCID: PMC3754879.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCTClinical Trials
    166. Significance of expression of ITGA5 and its splice variants in acute myeloid leukemia: a report from the Children's Oncology Group. Am J Hematol. 2013 Aug; 88(8):694-702. Walter RB, Laszlo GS, Alonzo TA, Gerbing RB, Levy S, Fitzgibbon MP, Gudgeon CJ, Ries RE, Harrington KH, Raimondi SC, Hirsch BA, Gamis AS, W McIntosh M, Meshinchi S. PMID: 23686445; PMCID: PMC3757130.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCellsCTClinical Trials
    167. Development and validation of a single-cell network profiling assay-based classifier to predict response to induction therapy in paediatric patients with de novo acute myeloid leukaemia: a report from the Children's Oncology Group. Br J Haematol. 2013 Jul; 162(2):250-62. Lacayo NJ, Alonzo TA, Gayko U, Rosen DB, Westfall M, Purvis N, Putta S, Louie B, Hackett J, Cohen AC, Cesano A, Gerbing R, Ravindranath Y, Dahl GV, Gamis A, Meshinchi S. PMID: 23682827; PMCID: PMC4654575.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    168. NUP98/JARID1A is a novel recurrent abnormality in pediatric acute megakaryoblastic leukemia with a distinct HOX gene expression pattern. Leukemia. 2013 Dec; 27(12):2280-8. de Rooij JD, Hollink IH, Arentsen-Peters ST, van Galen JF, Berna Beverloo H, Baruchel A, Trka J, Reinhardt D, Sonneveld E, Zimmermann M, Alonzo TA, Pieters R, Meshinchi S, van den Heuvel-Eibrink MM, Zwaan CM. PMID: 23531517.
      View in: PubMed   Mentions: 73     Fields:    Translation:HumansCells
    169. Effectiveness of supportive care measures to reduce infections in pediatric AML: a report from the Children's Oncology Group. Blood. 2013 May 02; 121(18):3573-7. Sung L, Aplenc R, Alonzo TA, Gerbing RB, Lehrnbecher T, Gamis AS. PMID: 23471307; PMCID: PMC3643758.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    170. Clinical significance of CD33 nonsynonymous single-nucleotide polymorphisms in pediatric patients with acute myeloid leukemia treated with gemtuzumab-ozogamicin-containing chemotherapy. Clin Cancer Res. 2013 Mar 15; 19(6):1620-7. Mortland L, Alonzo TA, Walter RB, Gerbing RB, Mitra AK, Pollard JA, Loken MR, Hirsch B, Raimondi S, Franklin J, Pounds S, Cao X, Rubnitz JE, Ribeiro RC, Gamis A, Meshinchi S, Lamba JK. PMID: 23444229; PMCID: PMC3602123.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    171. Anthracyclines during induction therapy in acute myeloid leukaemia: a systematic review and meta-analysis. Br J Haematol. 2013 Apr; 161(2):192-203. Teuffel O, Leibundgut K, Lehrnbecher T, Alonzo TA, Beyene J, Sung L. PMID: 23398482.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    172. Phase I/II trial of clofarabine and cytarabine in children with relapsed/refractory acute lymphoblastic leukemia (AAML0523): a report from the Children's Oncology Group. Pediatr Blood Cancer. 2013 Jul; 60(7):1141-7. Cooper TM, Razzouk BI, Gerbing R, Alonzo TA, Adlard K, Raetz E, Gamis AS, Perentesis J, Whitlock JA. PMID: 23335239; PMCID: PMC4605828.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    173. Children's Oncology Group's 2013 blueprint for research: acute myeloid leukemia. Pediatr Blood Cancer. 2013 Jun; 60(6):964-71. Gamis AS, Alonzo TA, Perentesis JP, Meshinchi S, COG Acute Myeloid Leukemia Committee. PMID: 23255301; PMCID: PMC4605815.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    174. FACS analysis of Stat3/5 signaling reveals sensitivity to G-CSF and IL-6 as a significant prognostic factor in pediatric AML: a Children's Oncology Group report. Blood. 2013 Feb 14; 121(7):1083-93. Redell MS, Ruiz MJ, Gerbing RB, Alonzo TA, Lange BJ, Tweardy DJ, Meshinchi S, Children's Oncology Group. PMID: 23243289; PMCID: PMC3575754.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    175. Generalization of Youden index for multiple-class classification problems applied to the assessment of externally validated cognition in Parkinson disease screening. Stat Med. 2013 Mar 15; 32(6):995-1003. Nakas CT, Dalrymple-Alford JC, Anderson TJ, Alonzo TA. PMID: 22949169.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    176. Predictors and short-term outcomes of hyperleukocytosis in children with acute myeloid leukemia: a report from the Children's Oncology Group. Haematologica. 2012 Nov; 97(11):1770-3. Sung L, Aplenc R, Alonzo TA, Gerbing RB, Gamis AS, AAML0531/PHIS Group. PMID: 22801969; PMCID: PMC3487455.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    177. High expression of neutrophil elastase predicts improved survival in pediatric acute myeloid leukemia: a report from the Children's Oncology Group. Leuk Lymphoma. 2013 Jan; 54(1):202-4. Gudgeon CJ, Harrington KH, Laszlo GS, Alonzo TA, Gerbing RB, Gamis AS, Raimondi SC, Hirsch BA, Meshinchi S, Walter RB. PMID: 22680764; PMCID: PMC3757129.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    178. Residual disease detected by multidimensional flow cytometry signifies high relapse risk in patients with de novo acute myeloid leukemia: a report from Children's Oncology Group. Blood. 2012 Aug 23; 120(8):1581-8. Loken MR, Alonzo TA, Pardo L, Gerbing RB, Raimondi SC, Hirsch BA, Ho PA, Franklin J, Cooper TM, Gamis AS, Meshinchi S. PMID: 22649108; PMCID: PMC3429302.
      View in: PubMed   Mentions: 107     Fields:    Translation:HumansCTClinical Trials
    179. Merging of the National Cancer Institute-funded cooperative oncology group data with an administrative data source to develop a more effective platform for clinical trial analysis and comparative effectiveness research: a report from the Children's Oncology Group. Pharmacoepidemiol Drug Saf. 2012 May; 21 Suppl 2:37-43. Aplenc R, Fisher BT, Huang YS, Li Y, Alonzo TA, Gerbing RB, Hall M, Bertoch D, Keren R, Seif AE, Sung L, Adamson PC, Gamis A. PMID: 22552978; PMCID: PMC3359580.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    180. Patients with Fanconi anemia and AML have different cytogenetic clones than de novo cases of AML. Pediatr Blood Cancer. 2012 Nov; 59(5):922-4. Rochowski A, Olson SB, Alonzo TA, Gerbing RB, Lange BJ, Alter BP. PMID: 22517793; PMCID: PMC3407278.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCellsCTClinical Trials
    181. Extending induced ROC methodology to the functional context. Biostatistics. 2012 Sep; 13(4):594-608. Inácio V, González-Manteiga W, Febrero-Bande M, Gude F, Alonzo TA, Cadarso-Suárez C. PMID: 22474123.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    182. Favorable survival maintained in children who have myeloid leukemia associated with Down syndrome using reduced-dose chemotherapy on Children's Oncology Group trial A2971: a report from the Children's Oncology Group. Cancer. 2012 Oct 01; 118(19):4806-14. Sorrell AD, Alonzo TA, Hilden JM, Gerbing RB, Loew TW, Hathaway L, Barnard D, Taub JW, Ravindranath Y, Smith FO, Arceci RJ, Woods WG, Gamis AS. PMID: 22392565; PMCID: PMC3879144.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCTClinical Trials
    183. Phase II study of 2-chlorodeoxyadenosine plus idarubicin for children with acute myeloid leukaemia in first relapse: a paediatric oncology group study. Br J Haematol. 2012 Mar; 156(5):649-55. Chaleff S, Hurwitz CA, Chang M, Dahl G, Alonzo TA, Weinstein H. PMID: 22512017.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    184. Correlation of CD33 expression level with disease characteristics and response to gemtuzumab ozogamicin containing chemotherapy in childhood AML. Blood. 2012 Apr 19; 119(16):3705-11. Pollard JA, Alonzo TA, Loken M, Gerbing RB, Ho PA, Bernstein ID, Raimondi SC, Hirsch B, Franklin J, Walter RB, Gamis A, Meshinchi S. PMID: 22378848; PMCID: PMC3335378.
      View in: PubMed   Mentions: 59     Fields:    Translation:HumansCTClinical Trials
    185. Life-threatening and fatal infections in children with acute myeloid leukemia: a report from the Children's Oncology Group. J Pediatr Hematol Oncol. 2012 Jan; 34(1):e30-5. Sung L, Buxton A, Gamis A, Woods WG, Alonzo TA. PMID: 22052170; PMCID: PMC4490686.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    186. Nonparametric Bayesian estimation of the three-way receiver operating characteristic surface. Biom J. 2011 Nov; 53(6):1011-24. Inácio V, Turkman AA, Nakas CT, Alonzo TA. PMID: 22069202.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    187. Estimation of the prevalence of Fanconi anemia among patients with de novo acute myelogenous leukemia who have poor recovery from chemotherapy. Leuk Res. 2012 Jan; 36(1):29-31. Rochowski A, Rosenberg PS, Alonzo TA, Gerbing RB, Lange BJ, Alter BP. PMID: 21974856; PMCID: PMC4008327.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    188. Prognostic implications of the IDH1 synonymous SNP rs11554137 in pediatric and adult AML: a report from the Children's Oncology Group and SWOG. Blood. 2011 Oct 27; 118(17):4561-6. Ho PA, Kopecky KJ, Alonzo TA, Gerbing RB, Miller KL, Kuhn J, Zeng R, Ries RE, Raimondi SC, Hirsch BA, Oehler V, Hurwitz CA, Franklin JL, Gamis AS, Petersdorf SH, Anderson JE, Godwin JE, Reaman GH, Willman CL, Bernstein ID, Radich JP, Appelbaum FR, Stirewalt DL, Meshinchi S. PMID: 21873548; PMCID: PMC3208275.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    189. Natural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: a report from the Children's Oncology Group Study A2971. Blood. 2011 Dec 22; 118(26):6752-9; quiz 6996. Gamis AS, Alonzo TA, Gerbing RB, Hilden JM, Sorrell AD, Sharma M, Loew TW, Arceci RJ, Barnard D, Doyle J, Massey G, Perentesis J, Ravindranath Y, Taub J, Smith FO. PMID: 21849481; PMCID: PMC3245202.
      View in: PubMed   Mentions: 49     Fields:    Translation:HumansCTClinical Trials
    190. AAML03P1, a pilot study of the safety of gemtuzumab ozogamicin in combination with chemotherapy for newly diagnosed childhood acute myeloid leukemia: a report from the Children's Oncology Group. Cancer. 2012 Feb 01; 118(3):761-9. Cooper TM, Franklin J, Gerbing RB, Alonzo TA, Hurwitz C, Raimondi SC, Hirsch B, Smith FO, Mathew P, Arceci RJ, Feusner J, Iannone R, Lavey RS, Meshinchi S, Gamis A. PMID: 21766293.
      View in: PubMed   Mentions: 106     Fields:    Translation:Humans
    191. A phase II study of amifostine in children with myelodysplastic syndrome: a report from the Children's Oncology Group study (AAML0121). Pediatr Blood Cancer. 2011 Dec 15; 57(7):1230-2. Mathew P, Gerbing R, Alonzo TA, Wallas T, Gong JZ, Jasty R, Jorstad DT, Raimondi SC, Chavez CM, Eisenberg NL, Hirsch B, Gamis A, Smith FO, Arceci RJ. PMID: 21681928.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    192. Soluble interleukin-2 receptor α activation in a Children's Oncology Group randomized trial of interleukin-2 therapy for pediatric acute myeloid leukemia. Pediatr Blood Cancer. 2011 Sep; 57(3):398-405. Lange BJ, Yang RK, Gan J, Hank JA, Sievers EL, Alonzo TA, Gerbing RB, Sondel PM. PMID: 21681921; PMCID: PMC3172052.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    193. Beyond the 3+3 method: expanded algorithms for dose- escalation in Phase I oncology trials of two agents. Clin Trials. 2011 Jun; 8(3):247-59. Braun TM, Alonzo TA. PMID: 21730075.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    194. Superior outcome of pediatric acute myeloid leukemia patients with orbital and CNS myeloid sarcoma: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2012 Apr; 58(4):519-24. Johnston DL, Alonzo TA, Gerbing RB, Lange BJ, Woods WG. PMID: 21618422; PMCID: PMC3165066.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCTClinical Trials
    195. Prognostic significance of additional cytogenetic aberrations in 733 de novo pediatric 11q23/MLL-rearranged AML patients: results of an international study. Blood. 2011 Jun 30; 117(26):7102-11. Coenen EA, Raimondi SC, Harbott J, Zimmermann M, Alonzo TA, Auvrignon A, Beverloo HB, Chang M, Creutzig U, Dworzak MN, Forestier E, Gibson B, Hasle H, Harrison CJ, Heerema NA, Kaspers GJ, Leszl A, Litvinko N, Lo Nigro L, Morimoto A, Perot C, Reinhardt D, Rubnitz JE, Smith FO, Stary J, Stasevich I, Strehl S, Taga T, Tomizawa D, Webb D, Zemanova Z, Pieters R, Zwaan CM, van den Heuvel-Eibrink MM. PMID: 21551233; PMCID: PMC3143552.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    196. Individual patient data meta-analysis of randomized trials evaluating IL-2 monotherapy as remission maintenance therapy in acute myeloid leukemia. Blood. 2011 Jun 30; 117(26):7007-13. Buyse M, Squifflet P, Lange BJ, Alonzo TA, Larson RA, Kolitz JE, George SL, Bloomfield CD, Castaigne S, Chevret S, Blaise D, Maraninchi D, Lucchesi KJ, Burzykowski T. PMID: 21518931; PMCID: PMC3539044.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansPHPublic Health
    197. Leukemic mutations in the methylation-associated genes DNMT3A and IDH2 are rare events in pediatric AML: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2011 Aug; 57(2):204-9. Ho PA, Kutny MA, Alonzo TA, Gerbing RB, Joaquin J, Raimondi SC, Gamis AS, Meshinchi S. PMID: 21504050; PMCID: PMC3115394.
      View in: PubMed   Mentions: 55     Fields:    Translation:HumansCells
    198. Bias in estimating accuracy of a binary screening test with differential disease verification. Stat Med. 2011 Jul 10; 30(15):1852-64. Alonzo TA, Brinton JT, Ringham BM, Glueck DH. PMID: 21495059; PMCID: PMC3115446.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    199. Higher dose imatinib for children with de novo chronic phase chronic myelogenous leukemia: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2011 Jul 15; 57(1):56-62. Champagne MA, Fu CH, Chang M, Chen H, Gerbing RB, Alonzo TA, Cooley LD, Heerema NA, Oehler V, Wood C, French ME, Arceci RJ, Smith FO, Bernstein ML. PMID: 21465636; PMCID: PMC5157124.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCTClinical Trials
    200. Stat3 signaling in acute myeloid leukemia: ligand-dependent and -independent activation and induction of apoptosis by a novel small-molecule Stat3 inhibitor. Blood. 2011 May 26; 117(21):5701-9. Redell MS, Ruiz MJ, Alonzo TA, Gerbing RB, Tweardy DJ. PMID: 21447830; PMCID: PMC3110027.
      View in: PubMed   Mentions: 129     Fields:    Translation:HumansCells
    201. Prevalence and clinical implications of NRAS mutations in childhood AML: a report from the Children's Oncology Group. Leukemia. 2011 Jun; 25(6):1039-42. Berman JN, Gerbing RB, Alonzo TA, Ho PA, Miller K, Hurwitz C, Heerema NA, Hirsch B, Raimondi SC, Lange B, Franklin JL, Gamis A, Meshinchi S. PMID: 21358716; PMCID: PMC4504732.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    202. Adequacy of visual inspection with acetic acid in women of advancing age. Int J Gynaecol Obstet. 2011 Apr; 113(1):68-71. Cremer M, Conlisk E, Maza M, Bullard K, Peralta E, Siedhoff M, Alonzo T, Felix J. PMID: 21272884.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansPHPublic Health
    203. WT1 synonymous single nucleotide polymorphism rs16754 correlates with higher mRNA expression and predicts significantly improved outcome in favorable-risk pediatric acute myeloid leukemia: a report from the children's oncology group. J Clin Oncol. 2011 Feb 20; 29(6):704-11. Ho PA, Kuhn J, Gerbing RB, Pollard JA, Zeng R, Miller KL, Heerema NA, Raimondi SC, Hirsch BA, Franklin JL, Lange B, Gamis AS, Alonzo TA, Meshinchi S. PMID: 21189390; PMCID: PMC3056655.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    204. Accuracy and cut-off point selection in three-class classification problems using a generalization of the Youden index. Stat Med. 2010 Dec 10; 29(28):2946-55. Nakas CT, Alonzo TA, Yiannoutsos CT. PMID: 20809485; PMCID: PMC2991472.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    205. Immediate vs. delayed post-abortal copper T 380A IUD insertion in cases over 12 weeks of gestation. Contraception. 2011 Jun; 83(6):522-7. Cremer M, Bullard KA, Mosley RM, Weiselberg C, Molaei M, Lerner V, Alonzo TA. PMID: 21570549.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    206. Cytology versus visual inspection with acetic acid among women treated previously with cryotherapy in a low-resource setting. Int J Gynaecol Obstet. 2010 Dec; 111(3):249-52. Cremer M, Bullard K, Maza M, Peralta E, Moore E, Garcia L, Masch R, Lerner V, Alonzo TA, Felix J. PMID: 20801447.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    207. The presence of central nervous system disease at diagnosis in pediatric acute myeloid leukemia does not affect survival: a Children's Oncology Group study. Pediatr Blood Cancer. 2010 Sep; 55(3):414-20. Johnston DL, Alonzo TA, Gerbing RB, Lange BJ, Woods WG. PMID: 20658610; PMCID: PMC2990693.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    208. MDM2 polymorphism increases susceptibility to childhood acute myeloid leukemia: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2010 Aug; 55(2):248-53. Phillips CL, Gerbing R, Alonzo T, Perentesis JP, Harley IT, Meshinchi S, Bhatla D, Radloff G, Davies SM. PMID: 20582981; PMCID: PMC2915901.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    209. High expression of the very late antigen-4 integrin independently predicts reduced risk of relapse and improved outcome in pediatric acute myeloid leukemia: a report from the children's oncology group. J Clin Oncol. 2010 Jun 10; 28(17):2831-8. Walter RB, Alonzo TA, Gerbing RB, Ho PA, Smith FO, Raimondi SC, Hirsch BA, Gamis AS, Franklin JL, Hurwitz CA, Loken MR, Meshinchi S. PMID: 20421533; PMCID: PMC2903318.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    210. Prevalence and prognostic implications of WT1 mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group. Blood. 2010 Aug 05; 116(5):702-10. Ho PA, Zeng R, Alonzo TA, Gerbing RB, Miller KL, Pollard JA, Stirewalt DL, Heerema NA, Raimondi SC, Hirsch B, Franklin JL, Lange B, Meshinchi S. PMID: 20413658; PMCID: PMC2918327.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansCells
    211. Molecular alterations of the IDH1 gene in AML: a Children's Oncology Group and Southwest Oncology Group study. Leukemia. 2010 May; 24(5):909-13. Ho PA, Alonzo TA, Kopecky KJ, Miller KL, Kuhn J, Zeng R, Gerbing RB, Raimondi SC, Hirsch BA, Oehler V, Hurwitz CA, Franklin JL, Gamis AS, Petersdorf SH, Anderson JE, Reaman GH, Baker LH, Willman CL, Bernstein ID, Radich JP, Appelbaum FR, Stirewalt DL, Meshinchi S. PMID: 20376086; PMCID: PMC2945692.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCells
    212. Diagnostic reproducibility of cervical intraepithelial neoplasia 3 and atrophy in menopausal women on hematoxylin and eosin, Ki-67, and p16 stained slides. J Low Genit Tract Dis. 2010 Apr; 14(2):108-12. Cremer ML, Alonzo TA, Alspach AE, Shulman IA, Cernosek S, Tsai S, Kalichanda N, Felix JC. PMID: 20354418.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    213. Estimates of sensitivity and specificity can be biased when reporting the results of the second test in a screening trial conducted in series. BMC Med Res Methodol. 2010 Jan 11; 10:3. Ringham BM, Alonzo TA, Grunwald GK, Glueck DH. PMID: 20064254; PMCID: PMC2819240.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    214. Prevalence and prognostic significance of KIT mutations in pediatric patients with core binding factor AML enrolled on serial pediatric cooperative trials for de novo AML. Blood. 2010 Mar 25; 115(12):2372-9. Pollard JA, Alonzo TA, Gerbing RB, Ho PA, Zeng R, Ravindranath Y, Dahl G, Lacayo NJ, Becton D, Chang M, Weinstein HJ, Hirsch B, Raimondi SC, Heerema NA, Woods WG, Lange BJ, Hurwitz C, Arceci RJ, Radich JP, Bernstein ID, Heinrich MC, Meshinchi S. PMID: 20056794; PMCID: PMC2845895.
      View in: PubMed   Mentions: 64     Fields:    Translation:Humans
    215. Digital assessment of the reproductive tract versus colposcopy for directing biopsies in women with abnormal Pap smears. J Low Genit Tract Dis. 2010 Jan; 14(1):5-10. Cremer ML, Peralta EI, Dheming SG, Jimenez ME, Davis-Dao CA, Alonzo TA, Blumenthal PD, Felix JC. PMID: 20040830.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimals
    216. WT1 expression at diagnosis does not predict survival in pediatric AML: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2009 Dec; 53(6):1136-9. Noronha SA, Farrar JE, Alonzo TA, Gerbing RB, Lacayo NJ, Dahl GV, Ravindranath Y, Arceci RJ, Loeb DM. PMID: 19618455; PMCID: PMC2926132.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    217. Treatment of children with acute promyelocytic leukemia: results of the first North American Intergroup trial INT0129. Pediatr Blood Cancer. 2009 Dec; 53(6):1005-10. Gregory J, Kim H, Alonzo T, Gerbing R, Woods W, Weinstein H, Shepherd L, Schiffer C, Appelbaum F, Willman C, Wiernik P, Rowe J, Tallman M, Feusner J. PMID: 19743516; PMCID: PMC3508725.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    218. A receiver operating characteristic analysis approach for the assessment of the separation of female Mediterranean fruit fly (Diptera: Tephritidae) oviposition distributions. J Econ Entomol. 2009 Oct; 102(5):1985-91. Alonzo TA, Nakas CT, Papadopoulos NT, Papachristos DP. PMID: 19886466.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    219. Effect of tidal volume in children with acute hypoxemic respiratory failure. Intensive Care Med. 2009 Aug; 35(8):1428-37. Khemani RG, Conti D, Alonzo TA, Bart RD, Newth CJ. PMID: 19533092.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    220. Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study. Blood. 2009 Sep 17; 114(12):2489-96. Balgobind BV, Raimondi SC, Harbott J, Zimmermann M, Alonzo TA, Auvrignon A, Beverloo HB, Chang M, Creutzig U, Dworzak MN, Forestier E, Gibson B, Hasle H, Harrison CJ, Heerema NA, Kaspers GJ, Leszl A, Litvinko N, Nigro LL, Morimoto A, Perot C, Pieters R, Reinhardt D, Rubnitz JE, Smith FO, Stary J, Stasevich I, Strehl S, Taga T, Tomizawa D, Webb D, Zemanova Z, Zwaan CM, van den Heuvel-Eibrink MM. PMID: 19528532; PMCID: PMC2927031.
      View in: PubMed   Mentions: 171     Fields:    Translation:HumansCells
    221. Comparing accuracy in an unpaired post-market device study with incomplete disease assessment. Biom J. 2009 Jun; 51(3):491-503. Alonzo TA. PMID: 19572317.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    222. Adolescent comprehension of emergency contraception in New York City. Obstet Gynecol. 2009 Apr; 113(4):840-844. Cremer M, Holland E, Adams B, Klausner D, Nichols S, Scott Ram R, Alonzo TA. PMID: 19305328.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    223. A comparison of tests for restricted orderings in the three-class case. Stat Med. 2009 Mar 30; 28(7):1144-58. Alonzo TA, Nakas CT, Yiannoutsos CT, Bucher S. PMID: 19156672.
      View in: PubMed   Mentions: 4     Fields:    
    224. Prevalence and prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group. Blood. 2009 Jun 25; 113(26):6558-66. Ho PA, Alonzo TA, Gerbing RB, Pollard J, Stirewalt DL, Hurwitz C, Heerema NA, Hirsch B, Raimondi SC, Lange B, Franklin JL, Radich JP, Meshinchi S. PMID: 19304957; PMCID: PMC2943755.
      View in: PubMed   Mentions: 72     Fields:    Translation:HumansCells
    225. Infections and association with different intensity of chemotherapy in children with acute myeloid leukemia. Cancer. 2009 Mar 01; 115(5):1100-8. Sung L, Gamis A, Alonzo TA, Buxton A, Britton K, Deswarte-Wallace J, Woods WG. PMID: 19156894; PMCID: PMC2677372.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansCTClinical Trials
    226. Methods for Assessing Improvement in Specificity when a Biomarker is Combined with a Standard Screening Test. Stat Biopharm Res. 2009 Feb 01; 1(1):18-25. Shaw PA, Pepe MS, Alonzo TA, Etzioni R. PMID: 20054437; PMCID: PMC2802069.
      View in: PubMed   Mentions: 11  
    227. Bias in trials comparing paired continuous tests can cause researchers to choose the wrong screening modality. BMC Med Res Methodol. 2009 Jan 20; 9:4. Glueck DH, Lamb MM, O'Donnell CI, Ringham BM, Brinton JT, Muller KE, Lewin JM, Alonzo TA, Pisano ED. PMID: 19154609; PMCID: PMC2657218.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic Health
    228. FAS promoter polymorphism: outcome of childhood acute myeloid leukemia. A children's oncology group report. Clin Cancer Res. 2008 Dec 01; 14(23):7896-9. Mehta PA, Gerbing RB, Alonzo TA, Elliott JS, Zamzow TA, Combs M, Stover E, Ross JA, Perentesis JP, Meschinchi S, Lange BJ, Davies SM. PMID: 19047119; PMCID: PMC2787450.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    229. Respiratory syncytial virus infections in children with acute myeloid leukemia: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2008 Dec; 51(6):784-6. Sung L, Alonzo TA, Gerbing RB, Aplenc R, Lange BJ, Woods WG, Feusner J, Franklin J, Patterson MJ, Gamis AS, Children's Oncology Group. PMID: 18680152; PMCID: PMC2727468.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    230. Cytidine deaminase genotype and toxicity of cytosine arabinoside therapy in children with acute myeloid leukemia. Br J Haematol. 2009 Feb; 144(3):388-94. Bhatla D, Gerbing RB, Alonzo TA, Conner H, Ross JA, Meshinchi S, Zhai X, Zamzow T, Mehta PA, Geiger H, Perentesis J, Davies SM. PMID: 19036079; PMCID: PMC3083240.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    231. Impact of disease risk on efficacy of matched related bone marrow transplantation for pediatric acute myeloid leukemia: the Children's Oncology Group. J Clin Oncol. 2008 Dec 10; 26(35):5797-801. Horan JT, Alonzo TA, Lyman GH, Gerbing RB, Lange BJ, Ravindranath Y, Becton D, Smith FO, Woods WG, Children's Oncology Group. PMID: 18955460; PMCID: PMC2645105.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    232. DNA methylation-based biomarkers for early detection of non-small cell lung cancer: an update. Mol Cancer. 2008 Oct 23; 7:81. Anglim PP, Alonzo TA, Laird-Offringa IA. PMID: 18947422; PMCID: PMC2585582.
      View in: PubMed   Mentions: 70     Fields:    Translation:HumansCells
    233. Disseminated intravascular coagulation score is associated with mortality for children with shock. Intensive Care Med. 2009 Feb; 35(2):327-33. Khemani RG, Bart RD, Alonzo TA, Hatzakis G, Hallam D, Newth CJ. PMID: 18802683.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    234. Safety and efficacy of gemtuzumab ozogamicin in combination with chemotherapy for pediatric acute myeloid leukemia: a report from the Children's Oncology Group. J Clin Oncol. 2008 May 10; 26(14):2390-3295. Aplenc R, Alonzo TA, Gerbing RB, Lange BJ, Hurwitz CA, Wells RJ, Bernstein I, Buckley P, Krimmel K, Smith FO, Sievers EL, Arceci RJ, Children's Oncology Group. PMID: 18467731; PMCID: PMC4558626.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCTClinical Trials
    235. Structural and numerical variation of FLT3/ITD in pediatric AML. Blood. 2008 May 15; 111(10):4930-3. Meshinchi S, Stirewalt DL, Alonzo TA, Boggon TJ, Gerbing RB, Rocnik JL, Lange BJ, Gilliland DG, Radich JP. PMID: 18305215; PMCID: PMC2384125.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansCells
    236. The MonoPrep Pap test for the detection of cervical cancer and its precursors. Part I: results of a multicenter clinical trial. Am J Clin Pathol. 2008 Feb; 129(2):193-201. Cibas ES, Alonzo TA, Austin RM, Bolick DR, Glant MD, Henry MR, Moriarty AT, Molina JT, Rushing L, Slowman SD, Torno R, Eisenhut CC. PMID: 18208798.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    237. Outcomes in childhood AML in the absence of transplantation in first remission--Children's Cancer Group (CCG) studies 2891 and CCG 213. Pediatr Blood Cancer. 2008 Jan; 50(1):9-16. Castellino SM, Alonzo TA, Buxton A, Gold S, Lange BJ, Woods WG. PMID: 17252564.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    238. DNA repair polymorphisms and outcome of chemotherapy for acute myelogenous leukemia: a report from the Children's Oncology Group. Leukemia. 2008 Feb; 22(2):265-72. Bhatla D, Gerbing RB, Alonzo TA, Mehta PA, Deal K, Elliott J, Meshinchi S, Geiger H, Perentesis JP, Lange BJ, Davies SM, Children's Oncology Group. PMID: 18033323; PMCID: PMC2914507.
      View in: PubMed   Mentions: 11     Fields:    Translation:Cells
    239. Outcomes in CCG-2961, a children's oncology group phase 3 trial for untreated pediatric acute myeloid leukemia: a report from the children's oncology group. Blood. 2008 Feb 01; 111(3):1044-53. Lange BJ, Smith FO, Feusner J, Barnard DR, Dinndorf P, Feig S, Heerema NA, Arndt C, Arceci RJ, Seibel N, Weiman M, Dusenbery K, Shannon K, Luna-Fineman S, Gerbing RB, Alonzo TA. PMID: 18000167; PMCID: PMC2214754.
      View in: PubMed   Mentions: 130     Fields:    Translation:HumansCTClinical Trials
    240. A modified sign test for comparing paired ROC curves. Biostatistics. 2008 Apr; 9(2):364-72. Braun TM, Alonzo TA. PMID: 17925302.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    241. Comparison of ROC umbrella volumes with an application to the assessment of lung cancer diagnostic markers. Biom J. 2007 Aug; 49(5):654-64. Alonzo TA, Nakas CT. PMID: 17726716.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    242. Microbiologically documented infections and infection-related mortality in children with acute myeloid leukemia. Blood. 2007 Nov 15; 110(10):3532-9. Sung L, Lange BJ, Gerbing RB, Alonzo TA, Feusner J. PMID: 17660380.
      View in: PubMed   Mentions: 80     Fields:    Translation:Humans
    243. Comparison of childhood myelodysplastic syndrome, AML FAB M6 or M7, CCG 2891: report from the Children's Oncology Group. Pediatr Blood Cancer. 2007 Jul; 49(1):17-22. Barnard DR, Alonzo TA, Gerbing RB, Lange B, Woods WG, Children's Oncology Group. PMID: 16856158.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    244. Autologous bone marrow transplantation for children with AML in first remission. Bone Marrow Transplant. 2007 Aug; 40(4):313-8. Neudorf S, Sanders J, Kobrinsky N, Alonzo TA, Buxton A, Buckley JD, Howells W, Gold S, Barnard DR, DeSwarte J, Kalousek D, Lange BJ, Woods WG. PMID: 17563741.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    245. ROC graphs for assessing the ability of a diagnostic marker to detect three disease classes with an umbrella ordering. Biometrics. 2007 Jun; 63(2):603-9. Nakas CT, Alonzo TA. PMID: 17688513.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    246. Criteria for optimizing prognostic risk groups in pediatric cancer: analysis of data from the Children's Oncology Group. J Clin Oncol. 2007 May 20; 25(15):2070-7. Sposto R, London WB, Alonzo TA, Children's Oncology Group. PMID: 17513812.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    247. The incidence and clinical significance of nucleophosmin mutations in childhood AML. Blood. 2007 Aug 01; 110(3):979-85. Brown P, McIntyre E, Rau R, Meshinchi S, Lacayo N, Dahl G, Alonzo TA, Chang M, Arceci RJ, Small D. PMID: 17440048; PMCID: PMC1924773.
      View in: PubMed   Mentions: 78     Fields:    Translation:HumansCells
    248. Monosomy 7 and deletion 7q in children and adolescents with acute myeloid leukemia: an international retrospective study. Blood. 2007 Jun 01; 109(11):4641-7. Hasle H, Alonzo TA, Auvrignon A, Behar C, Chang M, Creutzig U, Fischer A, Forestier E, Fynn A, Haas OA, Harbott J, Harrison CJ, Heerema NA, van den Heuvel-Eibrink MM, Kaspers GJ, Locatelli F, Noellke P, Polychronopoulou S, Ravindranath Y, Razzouk B, Reinhardt D, Savva NN, Stark B, Suciu S, Tsukimoto I, Webb DK, Wojcik D, Woods WG, Zimmermann M, Niemeyer CM, Raimondi SC. PMID: 17299091.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansCells
    249. Development and evaluation of classifiers. Methods Mol Biol. 2007; 404:89-116. Alonzo TA, Pepe MS. PMID: 18450047.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    250. Statistical methods for evaluating DNA methylation as a marker for early detection or prognosis. Dis Markers. 2007; 23(1-2):113-20. Alonzo TA, Siegmund KD. PMID: 17325431; PMCID: PMC3850861.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    251. Minimally differentiated acute myeloid leukemia (FAB AML-M0) is associated with an adverse outcome in children: a report from the Children's Oncology Group, studies CCG-2891 and CCG-2961. Blood. 2007 Mar 15; 109(6):2314-21. Barbaric D, Alonzo TA, Gerbing RB, Meshinchi S, Heerema NA, Barnard DR, Lange BJ, Woods WG, Arceci RJ, Smith FO. PMID: 17158236; PMCID: PMC1852193.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    252. Clinical implications of FLT3 mutations in pediatric AML. Blood. 2006 Dec 01; 108(12):3654-61. Meshinchi S, Alonzo TA, Stirewalt DL, Zwaan M, Zimmerman M, Reinhardt D, Kaspers GJ, Heerema NA, Gerbing R, Lange BJ, Radich JP. PMID: 16912228; PMCID: PMC1895470.
      View in: PubMed   Mentions: 158     Fields:    Translation:HumansCellsCTClinical Trials
    253. Role of allogeneic stem cell transplantation in FLT3/ITD-positive AML. Blood. 2006 Jul 01; 108(1):400; author reply 400-1. Meshinchi S, Arceci RJ, Sanders JE, Smith FO, Woods WB, Radich JP, Alonzo TA. PMID: 16790584.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    254. FLT3 internal tandem duplication in CD34+/CD33- precursors predicts poor outcome in acute myeloid leukemia. Blood. 2006 Oct 15; 108(8):2764-9. Pollard JA, Alonzo TA, Gerbing RB, Woods WG, Lange BJ, Sweetser DA, Radich JP, Bernstein ID, Meshinchi S. PMID: 16809615; PMCID: PMC1895585.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCells
    255. A novel design for estimating relative accuracy of screening tests when complete disease verification is not feasible. Biometrics. 2006 Jun; 62(2):605-12. Alonzo TA, Kittelson JM. PMID: 16918926.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansPHPublic Health
    256. A retrospective study of 69 patients with t(6;9)(p23;q34) AML emphasizes the need for a prospective, multicenter initiative for rare 'poor prognosis' myeloid malignancies. Leukemia. 2006 Jul; 20(7):1295-7. Slovak ML, Gundacker H, Bloomfield CD, Dewald G, Appelbaum FR, Larson RA, Tallman MS, Bennett JM, Stirewalt DL, Meshinchi S, Willman CL, Ravindranath Y, Alonzo TA, Carroll AJ, Raimondi SC, Heerema NA. PMID: 16628187.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCells
    257. Ethnicity and survival in childhood acute myeloid leukemia: a report from the Children's Oncology Group. Blood. 2006 Jul 01; 108(1):74-80. Children's Oncology Group, Aplenc R, Alonzo TA, Gerbing RB, Smith FO, Meshinchi S, Ross JA, Perentesis J, Woods WG, Lange BJ, Davies SM. PMID: 16537811; PMCID: PMC1895824.
      View in: PubMed   Mentions: 61     Fields:    Translation:Humans
    258. Using the ROC curve for gauging treatment effect in clinical trials. Stat Med. 2006 Feb 28; 25(4):575-90. Brumback LC, Pepe MS, Alonzo TA. PMID: 16220481.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    259. Risk factors and therapy for isolated central nervous system relapse of pediatric acute myeloid leukemia. J Clin Oncol. 2005 Dec 20; 23(36):9172-8. Johnston DL, Alonzo TA, Gerbing RB, Lange BJ, Woods WG. PMID: 16361619.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    260. Long-term results of children with acute myeloid leukemia: a report of three consecutive Phase III trials by the Children's Cancer Group: CCG 251, CCG 213 and CCG 2891. Leukemia. 2005 Dec; 19(12):2054-62. Smith FO, Alonzo TA, Gerbing RB, Woods WG, Arceci RJ, Children's Cancer Group. PMID: 16136168.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansCTClinical Trials
    261. Standards for reporting prognostic tumor marker studies. J Clin Oncol. 2005 Dec 20; 23(36):9053-4. Alonzo TA. PMID: 16301590.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    262. XPD Lys751Gln polymorphism in the etiology and outcome of childhood acute myeloid leukemia: a Children's Oncology Group report. Blood. 2006 Jan 01; 107(1):39-45. Mehta PA, Alonzo TA, Gerbing RB, Elliott JS, Wilke TA, Kennedy RJ, Ross JA, Perentesis JP, Lange BJ, Davies SM, Children's Oncology Group. PMID: 16150943.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    263. Postremission therapy for children with acute myeloid leukemia: the children's cancer group experience in the transplant era. Leukemia. 2005 Jun; 19(6):965-70. Alonzo TA, Wells RJ, Woods WG, Lange B, Gerbing RB, Buxton AB, Neudorf S, Sanders J, Smith FO, Feig SA. PMID: 15830007.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    264. Verification bias-corrected estimators of the relative true and false positive rates of two binary screening tests. Stat Med. 2005 Feb 15; 24(3):403-17. Alonzo TA. PMID: 15543634.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    265. Mortality in overweight and underweight children with acute myeloid leukemia. JAMA. 2005 Jan 12; 293(2):203-11. Lange BJ, Gerbing RB, Feusner J, Skolnik J, Sacks N, Smith FO, Alonzo TA. PMID: 15644547.
      View in: PubMed   Mentions: 96     Fields:    Translation:HumansCellsCTClinical Trials
    266. PTPN11 mutations in pediatric patients with acute myeloid leukemia: results from the Children's Cancer Group. Leukemia. 2004 Nov; 18(11):1831-4. Loh ML, Reynolds MG, Vattikuti S, Gerbing RB, Alonzo TA, Carlson E, Cheng JW, Lee CM, Lange BJ, Meshinchi S, Children's Cancer Group. PMID: 15385933.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansCells
    267. Elevated expression of the AF1q gene, an MLL fusion partner, is an independent adverse prognostic factor in pediatric acute myeloid leukemia. Blood. 2004 Nov 15; 104(10):3058-63. Tse W, Meshinchi S, Alonzo TA, Stirewalt DL, Gerbing RB, Woods WG, Appelbaum FR, Radich JP. PMID: 15217837.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCellsCTClinical Trials
    268. Pediatric AML primary samples with FLT3/ITD mutations are preferentially killed by FLT3 inhibition. Blood. 2004 Sep 15; 104(6):1841-9. Brown P, Meshinchi S, Levis M, Alonzo TA, Gerbing R, Lange B, Arceci R, Small D. PMID: 15166029.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    269. Allogeneic bone marrow transplantation for children with acute myelocytic leukemia in first remission demonstrates a role for graft versus leukemia in the maintenance of disease-free survival. Blood. 2004 May 15; 103(10):3655-61. Neudorf S, Sanders J, Kobrinsky N, Alonzo TA, Buxton AB, Gold S, Barnard DR, Wallace JD, Kalousek D, Lange BJ, Woods WG. PMID: 14751924.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    270. Small sample estimation of relative accuracy for binary screening tests. Stat Med. 2004 Jan 15; 23(1):21-34. Alonzo TA, Braun TM, Moskowitz CS. PMID: 14695637.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    271. Pilot study of idarubicin-based intensive-timing induction therapy for children with previously untreated acute myeloid leukemia: Children's Cancer Group Study 2941. J Clin Oncol. 2004 Jan 01; 22(1):150-6. Lange BJ, Dinndorf P, Smith FO, Arndt C, Barnard D, Feig S, Feusner J, Seibel N, Weiman M, Aplenc R, Gerbing R, Alonzo TA. PMID: 14701777.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    272. Extramedullary leukemia in children with newly diagnosed acute myeloid leukemia: a report from the Children's Cancer Group. J Pediatr Hematol Oncol. 2003 Oct; 25(10):760-8. Dusenbery KE, Howells WB, Arthur DC, Alonzo T, Lee JW, Kobrinsky N, Barnard DR, Wells RJ, Buckley JD, Lange BJ, Woods WG. PMID: 14528097.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    273. Mitoxantrone and cytarabine induction, high-dose cytarabine, and etoposide intensification for pediatric patients with relapsed or refractory acute myeloid leukemia: Children's Cancer Group Study 2951. J Clin Oncol. 2003 Aug 01; 21(15):2940-7. Wells RJ, Adams MT, Alonzo TA, Arceci RJ, Buckley J, Buxton AB, Dusenbery K, Gamis A, Masterson M, Vik T, Warkentin P, Whitlock JA, Children's Cancer Group Study 2951. PMID: 12885813.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCTClinical Trials
    274. Prognostic implications of t(10;11) translocations in childhood acute myelogenous leukemia: a report from the Children's Cancer Group. J Pediatr Hematol Oncol. 2003 Aug; 25(8):594-600. Casillas JN, Woods WG, Hunger SP, McGavran L, Alonzo TA, Feig SA, Children's Cancer Group. PMID: 12902910.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    275. The effects of intraoral splints on the masticatory system of pigs. J Oral Rehabil. 2003 Aug; 30(8):823-31. Sindelar BJ, Herring SW, Alonzo TA. PMID: 12880407.
      View in: PubMed   Mentions: 1     Fields:    Translation:Animals
    276. Increased age at diagnosis has a significantly negative effect on outcome in children with Down syndrome and acute myeloid leukemia: a report from the Children's Cancer Group Study 2891. J Clin Oncol. 2003 Sep 15; 21(18):3415-22. Gamis AS, Woods WG, Alonzo TA, Buxton A, Lange B, Barnard DR, Gold S, Smith FO, Children's Cancer Group Study 2891. PMID: 12885836.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansCTClinical Trials
    277. Activating mutations of RTK/ras signal transduction pathway in pediatric acute myeloid leukemia. Blood. 2003 Aug 15; 102(4):1474-9. Meshinchi S, Stirewalt DL, Alonzo TA, Zhang Q, Sweetser DA, Woods WG, Bernstein ID, Arceci RJ, Radich JP. PMID: 12702504.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansCells
    278. Estimating disease prevalence in two-phase studies. Biostatistics. 2003 Apr; 4(2):313-26. Alonzo TA, Pepe MS, Lumley T. PMID: 12925524.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansPHPublic Health
    279. Immunophenotypic evidence of leukemia after induction therapy predicts relapse: results from a prospective Children's Cancer Group study of 252 patients with acute myeloid leukemia. Blood. 2003 May 01; 101(9):3398-406. Sievers EL, Lange BJ, Alonzo TA, Gerbing RB, Bernstein ID, Smith FO, Arceci RJ, Woods WG, Loken MR. PMID: 12506020.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    280. Impact of granulocyte colony-stimulating factor use during induction for acute myelogenous leukemia in children: a report from the Children's Cancer Group. J Pediatr Hematol Oncol. 2002 Nov; 24(8):627-35. Alonzo TA, Kobrinsky NL, Aledo A, Lange BJ, Buxton AB, Woods WG. PMID: 12439034.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    281. Distribution-free ROC analysis using binary regression techniques. Biostatistics. 2002 Sep; 3(3):421-32. Alonzo TA, Pepe MS. PMID: 12933607.
      View in: PubMed   Mentions: 56     Fields:    
    282. Current controversies: which patients with acute myeloid leukaemia should receive a bone marrow transplantation?--an American view. Br J Haematol. 2002 Aug; 118(2):378-84. Chen AR, Alonzo TA, Woods WG, Arceci RJ. PMID: 12139721.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    283. Acute myeloid leukemia and myelodysplastic syndrome in children treated for cancer: comparison with primary presentation. Blood. 2002 Jul 15; 100(2):427-34. Barnard DR, Lange B, Alonzo TA, Buckley J, Kobrinsky JN, Gold S, Neudorf S, Sanders J, Burden L, Woods WG. PMID: 12091332.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCTClinical Trials
    284. Prognostic variables in newly diagnosed children and adolescents with acute myeloid leukemia: Children's Cancer Group Study 213. Leukemia. 2002 Apr; 16(4):601-7. Wells RJ, Arthur DC, Srivastava A, Heerema NA, Le Beau M, Alonzo TA, Buxton AB, Woods WG, Howells WB, Benjamin DR, Betcher DL, Buckley JD, Feig SA, Kim T, Odom LF, Ruymann FB, Smithson WA, Tannous R, Whitt JK, Wolff L, Tjoa T, Lampkin BC. PMID: 11960339.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    285. Sample size calculations for comparative studies of medical tests for detecting presence of disease. Stat Med. 2002 Mar 30; 21(6):835-52. Alonzo TA, Pepe MS, Moskowitz CS. PMID: 11870820.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansPHPublic Health
    286. Prospective study of 90 children requiring treatment for juvenile myelomonocytic leukemia or myelodysplastic syndrome: a report from the Children's Cancer Group. J Clin Oncol. 2002 Jan 15; 20(2):434-40. Woods WG, Barnard DR, Alonzo TA, Buckley JD, Kobrinsky N, Arthur DC, Sanders J, Neudorf S, Gold S, Lange BJ. PMID: 11786571.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCTClinical Trials
    287. Comparing disease screening tests when true disease status is ascertained only for screen positives. Biostatistics. 2001 Sep; 2(3):249-60. Pepe MS, Alonzo TA. PMID: 12933537.
      View in: PubMed   Mentions: 17     Fields:    
    288. Effects of intraoral splint wear on proteoglycans in the temporomandibular joint disc. Arch Biochem Biophys. 2000 Jul 01; 379(1):64-70. Sindelar BJ, Evanko SP, Alonzo T, Herring SW, Wight T. PMID: 10864442.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimals
    289. Comparisons of predictive values of binary medical diagnostic tests for paired designs. Biometrics. 2000 Jun; 56(2):345-51. Leisenring W, Alonzo T, Pepe MS. PMID: 10877288.
      View in: PubMed   Mentions: 117     Fields:    Translation:Humans
    290. Using a combination of reference tests to assess the accuracy of a new diagnostic test. Stat Med. 1999 Nov 30; 18(22):2987-3003. Alonzo TA, Pepe MS. PMID: 10544302.
      View in: PubMed   Mentions: 84     Fields:    Translation:HumansCells
    291. Evaluation of friction during sliding tooth movement in various bracket-arch wire combinations. Am J Orthod Dentofacial Orthop. 1999 Sep; 116(3):336-45. Loftus BP, Artun J, Nicholls JI, Alonzo TA, Stoner JA. PMID: 10474108.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    292. Are dental anomalies risk factors for apical root resorption in orthodontic patients? Am J Orthod Dentofacial Orthop. 1999 Aug; 116(2):187-95. Lee RY, Artun J, Alonzo TA. PMID: 10434093.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    293. Building community for the long-term: an intergenerational commitment. Gerontologist. 1999 Apr; 39(2):235-8. Hamilton G, Brown S, Alonzo T, Glover M, Mersereau Y, Willson P. PMID: 10224720.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    Todd's Networks
    Concepts (715)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (42)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    NIH Funding Acknowledgment: Important - All publications resulting from the utilization of SC CTSI resources are required to credit the SC CTSI grant by including the NIH funding acknowledgment and must comply with the NIH Public Access Policy.

    This site is running Profiles RNS version UCSF-v3.1.0-5-g94c7c43e on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.